Department of Cancer Biology, Vanderbilt University Medical Center
Vanderbilt Center for Bone Biology, Vanderbilt University Medical Center
Osteoblasts at Bone Site Promote Osteolytic Bone Metastasis
Background and Objective: Metastatic breast cancers are often associated with osteoclastic bone resorption, which releases active TGFβ in the bone. Increased TGFβ in the bone suppresses osteoblast differentiation. We have demonstrated that undifferentiated stromal cells (C2C12) secrete significantly higher TGFβ compared to committed osteoblasts (2T3). We hypothesize osteoblast-derived TGFβ may promote bone metastasis. Our objective was to investigate whether osteoblasts directly increase metastatic behavior of breast cancer cells to promote bone metastasis.
Methods: We have injected MDA-MB-231-GFP human breast cancer cells in female nude mice using intracardiac, intratibial, or subcutaneous models to assess bone metastasis and to test in vivo motility.
Results: Anti-TGFβ antibody 1D11 increased bone volume in addition to reducing tumor burden in the intracardiac model, suggesting an increase in osteoblast differentiation. Conditioned media from undifferentiated stromal cells (C2C12) increased motility (P < 0.001) of MDA-MB-231-GFP cells in a TGFβ-dependent fashion compared to committed osteoblasts (2T3). Subcutaneously injected MDA-MB-231 cells migrated toward contralaterally injected MG63 (secretes 125 pg/ml/106 cells TGFβ). When co-injected intratibially with MDA-MB-231 cells, MG63 cells significantly (P < 0.05) increased osteolytic lesion area compared with 2T3 cells (lesion area: 12,000 arbitrary units in MG63 versus 3,000 arbitrary units in 2T3). This increase in osteolysis may be due to the increased amount of secreted TGFβ from MG63.
Conclusions: Osteoblasts-derived TGFβ may influence motility and osteolysis of the breast cancer cells. Our future direction is to further investigate the role of undifferentiated osteoblasts in metastatic breast cancer to the bone.
Division of Surgical Oncology, Department of Surgery, Virginia Commonwealth University and Massey Cancer Center
Department of Biochemistry and Molecular Biology, Virginia Commonwealth University and Massey Cancer Center
Estradiol-Mediated Export of Sphingosine 1-Phosphate from Breast Cancer Cell Is Via Non-Genomic Effect of Estrogen Receptor and Not GPR30
Background and Objective: Sphingosine 1-phosphate (S1P) is an active lipid mediator that plays critical roles in breast cancer progression by causing cell proliferation, migration, and angiogenesis. S1P exerts its functions by binding to its specific receptors on the cell surface after it is intracellularly produced by sphingosine kinase 1 (SphK1). Recently, estradiol (E2), which binds to estrogen receptor (ER) or GPR30, has been identified as one of the stimulators of SphK1. Our objective is to elucidate how E2 mediates S1P export from breast cancer.
Methods: ER positive MCF-7 and negative MDA-MB-231 human breast cancer cells were used as models. Eighteen hours of incubation with ICI182780 were used to inhibit ER expression, and its short-term incubation and G-1 compound were used to stimulate GPR30. S1P was measured using 3H-labeled sphingosine, or mass spectrometer (LC-ESI-MS/MS).
Results: E2, but not EGF, phosphorylated SphK1 and released S1P hours earlier than SphK1 transcription was induced, although both produced S1P in the cells. Inhibition of ER using ICI182780 blocked E2-mediated S1P export, but not the baseline secretion. However, MDA-MB-231 cells did not export S1P at all. Further, stimulation of GPR30 using either short-time ICI182780 or G-1 did not induce S1P export.
Conclusions: This is the first demonstration that non-genomic effect of E2 on S1P export was mediated via ER and not GPR30. Since it has been clearly shown that S1P is involved in breast cancer survival, these findings may, at least in part, explain why ER positive breast cancers are less responsive to initial chemotherapy.
ZinserGlendon M.(presenting author)KashinkuntiSoumyaWaltzSusan E.Cancer and Cell Biology Department, University of Cincinnati
Vitamin D3 Signaling Within Breast Adipose Participates To Regulate Mammary Gland Development and Inhibit Breast Tumorigenesis
Background and Objective: Vitamin D3, a nutritionally modulated hormone, participates as a negative growth regulator of mammary gland development and transformation. However, the mechanism behind tissue-specific vitamin D3 synthesis, metabolism, and signaling to maintain glandular homeostasis and inhibit the onset of mammary transformation remains unknown. Our objective is to test the concept that vitamin D3 signaling in mammary adipose tissue contributes to the negative growth regulation of mammary epithelial cells. Our hypothesis is that the mammary adipose tissue bioactivates dietary 25-hydroxyvitamin D3 [25(OH)D3] to the active metabolite, 1a,25-dihydroxyvitamin D3 [1,25(OH)2D3], and induces adipocyte vitamin D3 receptor (VDR) signaling along with paracrine secretion of 1,25(OH)2D3 to surrounding mammary epithelial cells to regulate growth of normal and transformed breast epithelial cells.
Methods: We utilized mammary glands from VDR knockout (KO) and wild type (WT) mice for various procedures including ex vivo co-cultures with mammary epithelium and adipocytes, gene and protein expression assays, immunohistochemistry, and whole mounts.
Results: Breast adipocytes express essential signaling components of the vitamin D3 endocrine system and have the ability to bioactivate 25(OH)D3 to 1,25(OH)2D3, inducing mammary-specific vitamin D3-responsive gene expression, and modulate mammary development, suggesting that mammary adipose tissue participates in maintaining localized vitamin D3 homeostasis and contributes growth regulation of mammary epithelial cells in response to various hormonal stimulations.
Conclusions: Our work suggests that breast adipose tissue serves as a vital endocrine mediator of vitamin D3 signaling and offers a possible mechanism by which elevated 25(OH)D3 serum concentrations reduce the susceptibility to breast cancer.
Department of Obstetrics and Gynecology, David Geffen School of Medicine
Department of Microbiology, Immunology and Molecular Medicine, David Geffen School of Medicine
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine
Howard Hughes Medical Institute, University of California, Los Angeles
Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University
Establishment of an In Vivo Mouse Model for Endometrial Regeneration from Dissociated Populations of Endometrial Stroma and Epithelium
Background and Objective: Endometrial cancer is the most common gynecologic cancer in the United States. Understanding genetic mechanisms and the target cell population that can initiate endometrial carcinoma can help identify novel targeted therapeutics. A major obstacle has been lack of reliable in vivo mouse models that can accurately recapitulate human disease. Our objective is to establish an in vivo mouse model for regeneration of endometrial glands that can be used to study oncogenic transformation and isolate putative stem cells of endometrial glands.
Methods: An endometrial tissue recombination system has been established previously (Cunha 1976). In this model, endometrial glandular and stromal tissue fragments are recombined and regenerated into endometrial glands under the kidney capsule of a severe combined immunodeficiency (SCID) female mouse (Cunha 1976). To genetically manipulate endometrial stroma and epithelia independently with retro or lentiviral delivery vectors, we have established a modified version of this tissue recombination system. In our model, endometrial stroma and endometrial glands are dissociated into single cells, allowing genetic manipulation of each compartment. Dissociated stromal and epithelial cells are placed into a collagen plug and implanted under the kidney capsule of a SCID mouse for 6 to 8 weeks.
Results: Regenerated grafts in this model result in the formation of endometrial glandular-like structures closely resembling the native murine endometrium based on morphology and marker expression profile.
Conclusions: We have established a powerful in vivo regeneration system for murine endometrial cells that can be used to (1) study malignant transformation and (2) isolate putative stem cells (potential target cells for endometrial cancer).
University of Michigan
Young Women Diagnosed with Cancer: A Preliminary Description of Their Decision-Making Process Surrounding Fertility Preservation
Background and Objective: Advances in cancer therapy have dramatically lengthened survivorship for young women. Concurrently, breakthroughs in reproductive technologies have recently resulted in advanced fertility preservation treatment such as oocyte, embryo, and ovarian cryopreservation. This study focuses on the decision-making process of young women who are diagnosed with cancer and are confronted with the choice of undergoing or foregoing advanced fertility preservation treatment.
Methods: Women were recruited from two large research institutions and the Internet. All participants were newly diagnosed with cancer, were medically eligible for fertility preservation treatment, and had discussed treatment options with their physicians. A qualitative, naturalistic approach guided the analysis.
Results: The decision-making process of young women consists of six interrelated phases: absorbing the cancer diagnosis, accepting diminishing fertility, contemplating treatment, engaging in self-examination, selecting a course of action, and reflecting upon the decision. Within these phases, women responded to their cancer diagnosis and envisioned how an abbreviated fertility period may affect their lives. They contemplated fertility preservation treatment by applying their values about motherhood while weighing cost and perceived risk. Women experienced a period of introspection and ultimately reached a decision about whether to undergo treatment. Finally, the women reflected upon the meaning of their decision.
Conclusions: We identified six phases that young women progress through when making the decision to undergo or forgo fertility preservation treatment. Healthcare providers can optimize decision support by identifying where patients are in the process and providing phase-specific counseling.
SalihSana M.
(presenting author)
AlbayrakSametKapurArvinderSchool of Medicine and Public Health, University of Wisconsin
Protection of Granulosa Cells by MDR1 Retroviral Transfection
Background and Objective: Molecular shield of the ovary is a novel idea that aims at utilizing new compounds that protect the ovary from chemotoxicity. This investigation focuses on the effects of MDR1 on chemotherapy-induced granulosa cell toxicity.
Methods: Immortalized murine granulosa cell line (KK-15) was transduced with sf91m3 retrovirus vector, which contains the human MDR1, at PFU/cell and treated with 10 μM Paclitaxel, 1 μM Carboplatin, 5μM Doxorubicin, or combination chemotherapy for 5 days. For in vivo experiments, P-gp expression was assessed in mouse ovaries after intraovarian injection of sf91m3 retrovirus.
Results: KK-15 granulosa cells transduced with sf91m3 demonstrated high expression of biologically active MDR1, as shown by FACS using P-gp monoclonal antibody, Rhodamine 123 efflux assays, and western blot. KK-15 exhibited a dose-dependant resistance to cytotoxic agents when the cells were treated with Paclitaxel, Carboplatin, or Doxorubicin. Intraovarian injection of sf91m3 did not achieve transduction of murine ovarian tissues in vivo. The percentage of cells alive before and after (before/after) chemotherapy treatment in control and transduced KK-15 cells was untreated (98/95), Carboplatin (49/92), Doxorubicin (12/61), Paclitaxel (82/93), Dox/Carb (51/79), and Pacli/Carb (81/91).
Conclusions: Retroviral gene delivery of human MDR1 significantly reduces the severity of chemotherapy-induced murine granulosa cell toxicity and offered chemoprotection in an in vitro model. Molecular shielding of the ovaries by over expression of MDR1 might protect from chemotoxicity.
GroverAmelia C.
(presenting author)
1BearHarry1GinderGordon2
Department of Surgical Oncology, Virginia Commonwealth University Health System
Department of Medical Oncology, Virginia Commonwealth University Health System
How Should Women with Lobular Neoplasia on Core Biopsy Be Treated? A Literature Review
Background and Objective: Lobular neoplasia (LN) of the breast comprises lobular carcinoma in situ (LCIS) and atypical lobular hyperplasia (ALH). Traditionally a marker of an increased risk of breast cancer, they may be a preneoplastic lesion. Their management is controversial when identified on core needle biopsy (CNB) secondary to the risk of a synchronous and/or the development of a metachronous breast malignancy. Around 36,000 women each year have to decide on treatment options ranging from careful followup to mastectomy. A literature review was performed to assess if clinical or biologic markers would provide risk stratification for the presence of a synchronous or the development of a metachronous breast cancer for women with LN on CNB.
Methods: Pub Med was searched using “atypical lobular hyperplasia breast” and “lobular carcinoma in situ breast.” The retrieved abstracts were reviewed and the pertinent articles read, along with any key references from these articles.
Results: Multiple clinical and pathologic features have been evaluated for their predictive value. None consistently stratifies the risk for a synchronous and/or metachronous breast cancer for women with LN on CNB.
Conclusions: The significance and treatment of LN of the breast is controversial. There are no clear features of LN that define the risk of a synchronous and/or metachronous breast cancer. Research in invasive breast malignancies has identified biological makers that predict recurrence and direct treatment. Biological changes in lobular neoplasias and their correlation with clinical characteristics may be useful in defining treatment and significance.
Division of Radiobiology, Department of Radiation Oncology, Virginia Commonwealth University
Division of Surgical Pathology, Department of Pathology, Virginia Commonwealth University
Reciprocal Interactions between Extracellular Matrix Signaling and DNA Double-Strand Break Repair in Breast Cells
Background and Objective: Genomic instability and acquisition of invasiveness through extracellular matrix (ECM) accompany breast cancers. Using human breast cell lines HMT-3522 with non-invasive S1, pre-invasive S3-C, and invasive T4-2 counterparts, we found that (1) ECM signaling via β1 integrin regulates DNA double-strand break repair (DSBR) pathway homologous recombination (HR), and (2) some repair proteins, such as polo-like kinase 1 PLK1, are involved ECM invasion, designating these GISEM for Genome Instability and Extracellular Matrix invasion. Our objective is to decipher how ECM signaling regulates DSBR and, reciprocally, how DSBR genes function in invasion through ECM.
Methods: siRNA inhibition, chemical inhibitors, and blocking antibodies were used in HMT-3522 cells. We used a GFP-based assay for HR, transwell assays for invasion through Matrigel®, and immunohistochemistry for patient tissues.
Results: (1) In S1 cells, we found that the β1 integrin specific interactor ICAP1 is a negative mediator of ECM-to-HR signaling. Downstream ROCK1 is involved in mediating ECM signals to HR. The adherens junction protein E-cadherin, which is also upstream of ROCK1, regulates HR and mediates nuclear levels of RAD51, γ-H2AX, and beta-catenin. (2) DSBR protein MRE11/RAD50/NBS1 (MRN) levels are upregulated by ECM in S1 cells but not in S3-C and T4-2. MRN protein levels decrease in progression from benign to pre-invasive to invasive lesions in 48 patients. (3) The DSBR protein XRCC3 negatively regulates invasion in T4-2 cells. XRCC3 is downregulated in progression from S1 to S3-C to T4-2.
Conclusions: We deciphered new interactions between ECM and DSBR with potential significance in breast cancer.
Department of Family Medicine, University of Maryland School of Medicine
School of Pharmacy, University of MarylandPennsylvania State University
Terameprocol Efficacy Studies in HPV Infection Models: A Candidate Chemoprevention Agent in Cervical Cancer
Background and Objective: Tetra-O-Methyl Nordihydroguaiaretic Acid (terameprocol) has Sp1 promoter inhibition properties and anti-HPV effects via inhibition of the p97 promoter and anti-cancer effects via Cdc2 inhibition and G2/M arrest of dividing cells. Terameprocol is formulated as a vaginal ointment. Our objective is to demonstrate the efficacy of topical terameprocol against HPV in vitro and in vivo using the CRPV/rabbit model.
Methods: In vitro: A431 cells were plated at 2 × 105 cells/well in six-well cluster dishes. Replicate aliquots of HPV-11 were added to each representing an MOI of 150 particles/cell. Titrations were added 48 hours after addition of virus and incubated a further 72 hours. Cell cultures were harvested, lysed with Trizol reagent, and RNA prepared. Quantitative real-time polymerase chain reaction (PCR) was conducted to quantify the proportion of viral E1E4 transcripts (EC50) and a cellular reference RNA for the TATA-binding protein (CC50). In vivo: The CRPV rabbit model was used to determine efficacy of terameprocol 2% ointment and 2% terameprocol in DMSO. We induced skin papillomas using purified mE8-CRPV on scarified rabbit skin. Dosing regimes include 1% and 2% ointment, 2% solution in DMSO, and controls with white petroleum and DMSO.
Results: In vitro: We found good efficacy of terameprocol against HPV-11 infection (EC50 of 0.4 μg/ml, CC50 of 5.0 μg/ml, Selectivity Index of 12.5). In vivo CRPV/rabbit study: Terameprocol showed suppression of papilloma growth for group B (2% in petrolatum).
Conclusions: Terameprocol demonstrates encouraging anti-HPV activity in vitro and effectiveness at reducing CRPV-induced papillomas, with some cures observed. Other treatment groups showed no statistically significant reduction.
Department of Physical Therapy, University of DelawareNational Institute on Aging
Sex Differences in the Relationship of Serum Carotenoid Levels with Mortality Risk among Older U.S. Adults: The Third National Health and Nutrition Examination Survey (NHANES III)
Background and Objective: Serum carotenoid levels are the best measure for diets rich in fruits and vegetables. No study has examined sex differences in the association of serum carotenoids with mortality in a representative sample of older U.S. adults. We aim to examine whether low serum carotenoid levels relate to mortality risk among older adults and to determine whether the association differs by sex.
Methods: The sample included 2,683 adults (1,315 men, 1,368 women) ages 65 years and older from NHANES III. Weighted Cox models assessed the relationship between total serum carotenoids and all-cause mortality. Total serum carotenoids were the sum of serum beta-carotene, alpha-carotene, beta-cryptoxanthin, lycopene, lutein, and zeaxanthin.
Results: The median total serum carotenoid level was 1.43 μmol/L (interquartile range: 1.00, 1.93 μmol/L). Women had higher median total serum carotenoids than men (1.55 v. 1.25 μmol/L, p < 0.001). Women had 455 deaths in 123,301 person-years; men had 643 deaths in 106,530 person-years. After adjusting for covariates, men in the lowest carotenoid quartile had a 17% higher all-cause mortality rate than men in the upper three carotenoid quartiles (incidence rate ratio [IRR] 1.17, 95% confidence interval [CI] 0.96–1.43, p = 0.13); and women in the lowest carotenoid quartile had a 53% higher all-cause mortality rate than women in the upper three carotenoid quartiles (IRR 1.53, 95% CI 1.16–2.02, p = 0.002). The IRRs were not significantly different (p-value for interaction = 0.12).
Conclusions: The findings show a strong association between low total serum carotenoid levels and all-cause mortality in women, but not men, among a representative sample of older U.S. adults.
WuJennifer M.
(presenting author)
1StinnettSandra2KuppermannMiriam3
Department of Obstetrics and Gynecology, Duke University, San Francisco
Department of Biostatistics, Duke University, San Francisco
Department of Obstetrics and Gynecology, University of California, San Francisco
Prevalence and Incidence of Urinary Incontinence in a Longitudinal Study of a Diverse Cohort of Women with Benign Gynecologic Conditions
Background and Objective: The proportion of women presenting with bleeding, pelvic pain, and fibroids, who also have urinary incontinence (UI) is not clear. Our objective is to determine the prevalence and incidence of UI in a diverse cohort of women with gynecologic conditions who participated in a 4-year longitudinal study and to assess factors associated with UI prevalence and incidence.
Methods: We conducted a secondary data analysis of SOPHIA (Study of Pelvic Problems, Hysterectomy, and Intervention Alternatives), a longitudinal study of women with benign gynecologic conditions (bleeding, pelvic pain, and fibroids). Urinary incontinence was defined as UI in the last 4 weeks, based on interviewer-administered annual questionnaires. UI type (stress [SUI], urge [UUI], or mixed incontinence [MUI]) was also evaluated.
Results: 907 women were included: 40.8% White, 28.0% Black, 17.3% Latina, and 8.1% Asian. The mean age was 44.1 ± 5.4 years. The overall prevalence of any UI was 51.1%. At baseline, SUI was most common (39.4%), followed by UUI (23.7%), and MUI (18.9%). The average annual incidence for any UI was 4.2%: 4.0% SUI, 3.5% UUI, and 3.4% MUI. Prevalent UI was associated with age in decades (Odds Ratio [OR] 1.4, 95% CI 1.1–1.8), parity (OR 1.8, 95% CI 1.3–2.3) and ethnicity (Latina compared to White; OR 2.0, 95% CI 1.3–3.0). None of the factors was associated with incidence of UI.
Conclusions: In a diverse population of women with benign gynecologic conditions, over half of the women have urinary incontinence. Providers should ask about UI symptoms when treating patients with benign uterine conditions.
KavanaghKimberly L.1RandsVicky F.1MartinVictoria L.1PrietoMinolfa C.
(presenting author)
123
Department of Physiology, Tulane University School of Medicine, New Orleans
Hypertension and Renal Center, Tulane University School of Medicine, New Orleans
Tulane-BIRCWH Program, Tulane University School of Medicine, New Orleans
Effect of High-Salt Diet on Renin and Prorenin Receptors in Kidney Distal Nephron Segments May Help To Explain Sex-Dependent Differences in the Development and Progression of High Blood Pressure and Renal Injury
Background and Objective: Hypertension and kidney injury are more severe in men than in women. Collecting duct (CD) renin and prorenin receptors [(P)RR], components of the renin-angiotensin system, play a role in AngII-dependent hypertension. Our objective is to determine if the effect of a high salt diet (HS) on CD renin and (P)RR gene expression contributes to sex-dependent differences in systolic blood pressure (SBP) and proteinuria in chronic AngII-infused male (n = 23) and female (n = 22) rats.
Results: Baseline SBP did not differ between males and females (116 ± 3 v. 119 ± 2 mmHg) or after AngII infusions (228 ± 9 v. 217 ± 20 mmHg). HS added to AngII-infusion did not modify SBP (228 ± 13 v. 211 ± 16 mmHg); however, it increased proteinuria to a greater extent in male than females (79 ± 6 v. 47 ± 6 mg/day). CD renin-mRNA levels were higher in males than females (1.0 ± 0.4 v. 0.2 ± 0.06 au). HS increased renin-mRNA in females but not in males (1.1 ± 0.1 v. 2.5 ± 0.4 au). Renin protein levels were similar in male and female rats, but prorenin levels were higher only in females. HS increased prorenin only in female rats (0.4 ± 0.3 v. 3.1 ±0.4 au). Male and female rats exhibited similar increased renin gene expression during AngII infusions. Although baseline (P)RR-mRNA levels were twice higher in female than male rats, HS down-regulated the (P)RR-mRNA only in females (male [controls = 1.7 ± 0.1 v. HS = 1.9 ± 0.1], female [controls = 3.2 ± 0.4 v. HS = 2.1 ± 0.2]).
Conclusions: HS does not exert additive effect on SBP nor contribute to SBP sexual dimorphism. Augmented proteinuria in males at SBP comparable to females may reflect a greater degree of renal injury, which might be explained by the increased CD renin and (P)RR gene expression. During HS, (P)RR down-regulation in female rats may represent a protective mechanism against kidney injury in this gender.
SahaSumona
(presenting author)
1EspostiSilvia Degli2
Section of Gastroenterology and Hepatology, University of Wisconsin School of Medicine and Public Health
Center for Women's Digestive Disorders, Women and Infants Hospital, Alpert Medical School of Brown University
Creation of a Women's Health Training Program in Gastroenterology
Background and Objective: Women's health tracks have been developed to address deficiencies in women's health education. Likewise, women's health competencies have been integrated into training programs. However, knowledge and confidence in evaluating and managing women's health issues remain low. In gastroenterology, nearly 60% of patients are female. Training in gastrointestinal (GI) women's health is, therefore, critical. Our objective is to (1) create a GI women's health training experience and (2) develop academic gastroenterologists focused on GI women's health.
Methods: (1) A multidisciplinary group of GI women's health experts was formed; (2) focus groups with primary care providers and sub-specialists were held to determine unmet needs in the management of the GI health of female patients; (3) a syllabus was developed for self-directed learning; (4) rotation in GI women's health was introduced for trainees in general gastroenterology; and (5) GI women's health track was introduced for trainees committed to academic careers.
Results: Since 2002, 13 fellows who participated in the rotation have graduated from the Brown GI fellowship program. One fellow has completed the track. Satisfaction with the program is high. All graduates participating in the rotation for a minimum of 1 to 2 months rated their training in GI women's health “just right.” Participating graduates also felt prepared to manage pregnancy and other GI women's health issues. The graduate of the track is a clinician-researcher at an academic center.
Conclusions: A training experience in GI women's health can be created using local resources and expertise. Gastroenterologists with this training feel prepared to evaluate and manage the spectrum of women's health issues encountered in practice.
KopcowHernan D.
(presenting author)
KarumanchiAnanthBeth Israel Deaconess Medical Center, Harvard Medical School
Decidual NK Cell–Decidual Monocyte Crosstalk Inhibits the Secretion of Antiangiogenic Molecules
Background and Objective: Preeclampsia is a complication affecting 3–5% of all pregnancies with significant implications not only for the offspring's health but also for the future of the mother's health. It is characterized by hypertension, edema, placental ischemia, and proteinuria. Preeclampsia can evolve into eclampsia, manifested by seizures, and can cause maternal death. High expression of placental soluble factors with antiangiogenic function, like soluble fms-like tyrosine kinase1 (sFlt1), has been associated with the disease. Decidual NK cells (dNK) and monocytes (dMo), the two main decidual leukocyte populations, secrete proangiogenic factors and are thought to play an important role in establishing proper placental vascular architecture. We hypothesized that dysregulation of dNK and dMo signaling may be involved in the abnormal placental angiogenesis that accompanies preeclampsia.
Methods: The effects of hypoxia on cytokine secretion by freshly isolated dMo and dNK cells were explored.
Results: Hypoxia increased the secretion of sFlt1 by both dNK and dMo. However, co-culture of dNK and dMo resulted in a drastic reduction of the levels of sFlt1 secreted. This effect was NKG2D mediated, as competition with NKG2D-Fc fusion protein prevented the suppression of sFlt1 secretion. Interestingly, NKG2D is differentially expressed in preeclamptic and normal placentas, as indicated by microarray gene expression profiling.
Conclusions: dNK-dMo crosstalk seems to be important for regulation of the delicate balance of pro and antiangiogenic factors required for proper placental vascular architecture. The relevance of these findings to human preeclampsia is being actively pursued in the laboratory and has important implications for women's health.
Department of Surgery, Tulane University School of Medicine
Department of Community Health Sciences, Tulane University School of Public Health and Tropical Medicine
Department of Medicine, Tulane University School of MedicineTulane Abdominal Transplant Institute
Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine
Risk of Graft Loss Lowered for Female Recipients of Male Kidneys When Donors Are Larger
Background and Objective: Female recipients of male donor kidneys compared to all other gender combinations may have the worst graft survival, and patients who receive larger kidneys relative to their body size may have a graft survival advantage. We speculated that the inferior graft survival for female recipients of male kidneys may be improved if kidneys are from larger, male donors.
Methods: We studied 668 kidney transplants retrospectively. Univariate correlations were calculated using Pearson's correlation coefficient, and 3-year graft survival was determined by Kaplan-Meier estimation. Multivariate methods were performed to determine the hazards of graft loss.
Results: We identified 146 male to female transplants. This group compared to all others had the lowest graft survival (86%, 79%, and 78% v. 92%, 88%, and 86% at 1, 2, and 3 years, respectively, log-rank p = 0.01). Donor body mass index (BMI) and kidney surface area directly correlated (r = 0.396, p <0001). Multivariate analysis showed that female recipients of male kidneys had a significant risk of graft loss (HR = 2.86, 95% CI 1.25–6.58, p = 0.01]). Male donors with a BMI two units larger than that of the female recipient resulted in a significantly lower risk of graft loss (HR = 0.19, 95% CI 0.05–0.67, p = 0.01).
Conclusions: The reduction in graft survival experienced by female recipients of male kidneys appears attenuated when grafts are from larger, male donors. Because kidney size correlated with BMI, this beneficial effect is likely due to greater nephron mass provided by larger, male donors.
Department of Radiological Sciences, Washington University School of Medicine
Department of Radiation Oncology, Washington University School of Medicine
Division of Hematology and Oncology, University of California, Davis Cancer Center
Molecular Imaging Center, Washington University School of Medicine
Imaging Sites of Metastasis Before They Happen: Targeting the Premetastatic Niche
Background and Objective: Bone marrow-derived hematopoietic progenitor cells (HPCs) that express the integrin a4β1 arrive at future sites of metastasis and form a receptive environment for tumor cells known as the premetastatic niche. The purpose of this project is to target a4β1 as an in vivo biomarker of the premetastatic niche using the high affinity ligand 64Cu-CB-TE2A-LLP2A and positron emission tomography (PET).
Methods: In this preliminary study, a4β1-negative MDA-MB-231/luc human breast tumor cells were implanted intra-arterially into mice. Metastasis developed spontaneously in multiple sites. The mice were monitored over a period of 30 days post-implantation by a combined bioluminescence (BLI)/microPET/microCT imaging study to determine whether increases in PET signal with 64Cu-CB-TE2A-LLP2A were observed prior to the development of luc+tumors in bone.
Results: Cumulative standardized uptake value data from an experiment with eight mice imaged on days −3 (control), 4, 10, 16, and 30 post-tumor cell injection show increased uptake of 64Cu-CB-TE2A-LLP2A over 30 days (p < 0.0001) at sites of bony metastasis. Preliminary histology and BLI data validate the influx of tumor cells at sites of PET signal.
Conclusions: These results suggest that PET imaging of the premetastatic niche is feasible. Future work will include (1) determination of the timing of HPC and tumor cell migration in mouse models of metastasis; (2) analysis of a4β1 expression in HPCs isolated from total marrow in tumor-bearing and tumor naïve mice; and (3) visualization of changes in the pattern of metastatic disease using circulating factors from primary tumor cells.
ZhangJian-Min
(presenting author)
1McCarthyMargaret M.12
Department of Psychiatry, University of Maryland School of Medicine
Department of Physiology, University of Maryland School of Medicine
The Role of Androgens in the Gender Difference of Major Depression: An Animal Model
Background and Objective: Women are twice as likely as men to suffer from major depression. Evidence indicates that androgens protect men from depression and contribute to this gender difference. The depression prevalence is similar between boys and girls. The gender difference in depression emerges in adolescence, paralleling the androgen surge in adolescent males. This has led to a general assumption that it is the adolescent androgen surge that underlies the gender difference in depression. However, little research has been done to explore the effects of perinatal androgen on depression. We want to determine whether perinatal androgens are antidepressant and whether the antidepressant effects of androgens associate with hippocampal neurogenesis.
Methods: Male pups were treated with vehicle or flutamide (androgen receptor antagonist) on post-natal day (PND) 0 and 1 to block neonatal androgen action. The depression-like behaviors were determined using the Forced Swimming Test (FST) and the Sucrose Preference Test (SPT) in preadolescent male rats. Doublecortin+neurons in the dentate gyrus, and the dendritic spines of pyramidal neurons in the CA1 region of the hippocampus were determined using immunohistochemistry and the Golgi-Cox technique, respectively.
Results: Neonatal-flutamide treatment caused not only a significant increase in depression-like behaviors, but also a decrease in doublecortin+neurons in the DG region and a decrease in the density of dendritic spines of pyramidal neurons in the CA1 region in preadolescent male rats.
Conclusions: Neonatal androgens may play an important role in protecting male rats from depression-like behaviors and promoting hippocampal neurogenesis in preadolescent male rats.
MarshallAmy D.
(presenting author)
1Holtzworth-MunroAmy2
Department of Psychology, Pennsylvania State University
Indiana University
Recognition of Wives' Emotional Expressions: A Mechanism in the Relationship Between Psychopathology and Intimate Partner Violence Perpetration
Background and Objective: Each year, approximately 14% of U.S. couples experience male-to-female intimate partner violence (IPV), frequently resulting in physical injuries and serious physical and psychological health consequences for women. The study of violent husbands' emotion recognition deficits is promising in terms of its theoretical base and implications for psychological therapies. We examine whether husbands' emotion recognition deficits serve as a mechanism in the relationship between two dimensions of psychopathology that commonly describe violent husbands and their IPV perpetration.
Methods: Among 88 community couples, both partners reported on male-to-female IPV. Husbands completed self-report measures of psychopathology. Wives were trained and photographed making facial expressions of emotions. Husbands completed an emotion recognition task including photographs of their wives and unfamiliar men and women displaying similar expressions.
Results: Husbands' diminished sensitivity to their wives' expressions of happiness partially mediated the relationship between their borderline/dysphoric characteristics and IPV perpetration. These relationships were specific to expressions of happiness displayed by their wives. In addition, husbands' IPV was associated with their diminished sensitivity to expressions of fear and their psychopathic personality characteristics were associated with misidentifying fearful expressions as neutral. However, the strength of husbands' sensitivity to fear as a mediator of the psychopathy-IPV relationship was suboptimal.
Conclusions: Study results support theories of IPV perpetration, demonstrate the significance of the intimate relationship, and question the applicability of a theory of extramarital violence to IPV. Implications exist for partner-specific emotion recognition training in therapies to prevent husbands' use of IPV, leading to improved health outcomes for women.
TempleJeff R.
(presenting author)
RuppRichard“Fred” ThomasJohn F.University of Texas Medical Branch at Galveston
Ethnic and Gender Disparities in Needed Adolescent Mental Health Care
Background and Objective: Mental illness is overlooked and undertreated in adolescents, especially with respect to low-income and ethnically diverse youth. Even after controlling for income and insurance status, minority youth are less likely than their White counterparts to receive needed care. The evidence is mixed on whether gender predicts receipt of needed care. School-based health centers are one way to increase healthcare utilization and may be particularly important for accessing hard-to-reach populations. The present study examines an ethnically diverse sample with equivalent access to a culturally sensitive school-based mental health clinic.
Methods: Participants included 1,712 African-American (31%), Hispanic (38%), and White (31%) high school students in southeast Texas. Adolescents completed the CES-D and self-reported on four indicators of access and use of mental health services.
Results: Of the sample, 26% had scores indicative of major depression and 18% had scores consistent with subthreshold depression. Across all ethnicities, the prevalence of depressive symptoms was highest among females. Depressed adolescent girls were more likely than their male counterparts to have received a medical diagnosis of depression, disclose depressive symptoms to an adult, and have a friend who sought treatment for depression. Similarly, depressed White students were more likely than minority youth to report having received a medical diagnosis of depression, have a friend who sought treatment for depression, and have been treated for depression.
Conclusions: These findings suggest that gender and ethnic disparities in obtaining needed mental health care may persist, even when providing equivalent access to a school-based mental health service.
FeltensteinMatthew W.
(presenting author)
SmallsBernardIIBoatwrightSarahGheeShannonSeeRonaldDepartment of Neurosciences, Medical University of South Carolina
Sex Differences in Nicotine Self-Administration and Reinstatement in Rats
Background and Objective: Nicotine addiction constitutes a substantial worldwide health issue that is particularly detrimental to women's health. However, traditional smoking-cessation programs result in poorer outcomes in women. Despite these issues, little research has been devoted to ascertaining sex differences in ongoing nicotine-taking and nicotine-seeking behaviors following exposure to various stimuli that contribute to relapse (e.g., conditioned cues, stress, and nicotine exposure). We examined sex differences in nicotine self-administration and reinstatement.
Methods: Male and female Sprague-Dawley rats were trained to lever press for intravenous nicotine (0.05 mg/kg/infusion) paired with the presentation of a light+tone stimulus during 15 daily 2-hour sessions. Once responding was extinguished in the absence of nicotine reinforcement, the ability of nicotine-paired cues, the anxiogenic drug yohimbine (2.5 mg/kg, IP, alone and in combination with the nicotine-paired cues), and a priming injection of nicotine (0.5 mg/kg, IP) were examined for their ability to reinstate nicotine-seeking behavior.
Results: Both males and females readily acquired nicotine self-administration and displayed comparable levels of responding and nicotine intake during the maintenance phase. In addition to yohimbine resulting in reinstatement of nicotine-seeking, yohimbine pretreatment in combination with the cues resulted in a supra-additive effect, with females exhibiting greater nicotine-seeking behavior under both reinstatement conditions. However, no sex differences were noted during conditioned-cued or greater nicotine-primed reinstatement.
Conclusions: Given these differences in reinstatement behavior following exposure to various relapsing stimuli, our results suggest that understanding sex differences in relapse to nicotine-seeking will facilitate the development of gender-specific treatment strategies and improve abstinence outcomes for female smokers.
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina
Department of Neurosciences, Medical University of South Carolina
Regional Areas of Brain Activation During Attempts To Resist Craving in Nicotine-Dependent Smokers: Preliminary fMRI Findings
Background and Objective: A strong association between craving and relapse to smoking during quit attempts among nicotine-dependent smokers has been demonstrated. Few studies have investigated the underlying neurological substrates during attempts to resist craving. We studied areas of regional brain activation during fMRI cue-induced craving and efforts to resist craving.
Methods: Participants (N = 4, F = 3) represent a pilot group of a larger sample of smokers participating in several fMRI craving studies. Participants were healthy, right-handed, non-treatment-seeking, nicotine-dependent adult smokers without major psychopathology and clinically significant medical problems. Two identical block design studies of fMRI cue-induced craving were completed after 2 hours of abstinence. During the first scan, participants were instructed to allow themselves to crave during cue presentation. During the second scan the instructions were varied to resist craving during the presentation of the smoking cues.
Results: Global brain activation decreased between craving and resist scans in 75% of the participants. The scans obtained during attempts to resist craving demonstrated increased right insula and temporal lobe activity compared to the craving scans. Craving scans showed more activity in bilateral middle prefrontal, middle cingulum, caudate nucleus, orbital frontal, and thalamus than resist scans.
Conclusions: Craving and cognitive strategies to resist craving utilize different regions of the brain. Recently, the amygdala has been implicated as a critical brain region involved in cigarette addiction. The insula has been demonstrated to have a potential role in the emotional and cognitive processes that promote drug use and may also be associated with craving resistance.
BuhusiMona C.
(presenting author)
GranholmAnn-CharlotteDepartment of Neurosciences, Medical University of South Carolina
BDNF Processing and Signaling in the Aged Mouse Hippocampus
Background and Objective: Aging-associated cognitive decline is a frequent condition among individuals ages 60 and over (prevalence estimated at 20–27%) and is of high use for the identification of preclinical stages of dementia. Deficits in memory tasks are related to dysfunctions of the hippocampus and cholinergic neurons projecting to the hippocampus and cortex. Neurotrophins regulate critically important processes in developing and adult brains, including neuronal survival, synaptogenesis, and synaptic plasticity and may play important roles in preventing aging-related degeneration. However, the neurotrophin precursors pro-nerve growth factor (proNGF) and pro-brain-derived neurotrophic factor (proBDNF) are detrimental for neuronal survival and function in vitro. Our objective is to identify changes in neurotrophin processing and signaling associated with aging and hormonal changes after menopause that may underlie memory dysfunction in females.
Methods: We analyzed memory function in aged v. young male and female mice (ovariectomized, estrogen, or placebo treated) using two behavioral testing paradigms (contextual fear conditioning and radial water maze). BDNF processing and signaling in the aged v. young mouse hippocampus (estrogen treated and placebo) were evaluated using biochemical assays.
Results and Conclusions: We identified significant differences in BDNF and in the p75 receptor expression in aged v. young mouse hippocampus. Alterations in BDNF processing and signaling in the aged hippocampus correlated with memory performance, suggesting that they may contribute to memory impairment in aged animals.
DarnallBeth D.Department of Anesthesiology and Perioperative Medicine, Oregon Health & Science University
Hysterectomy Is Associated With Opioid Use in Women with Chronic Pain
Background and Objective: Hysterectomy is the most common major surgical procedure for U.S. women younger than 45. The prevalence of chronic pelvic pain after hysterectomy is well described, yet a lack of information on non-pelvic chronic pain after hysterectomy remains. Prevalence of hysterectomy and its association with pain, psychosocial factors, and opioid use may inform treatment needs in this population. Our objectives are to (1) describe the prevalence of hysterectomy for women ages 18–45 receiving treatment in a chronic pain clinic; (2) characterize pain and opioid usage by age and hysterectomy status; and (3) determine whether hysterectomy predicts opioid use controlling for pain, age, and psychosocial factors.
Methods: Using a cross-sectional design, we charted a review of pain clinic records for all new female patients ages 18–45 being treated in a multidisciplinary pain clinic during a 12-month period (N = 453). Extracted data included hysterectomy status, age, average pain intensity, current opioid prescription (yes or no), and diagnoses for depression, anxiety, and pain type.
Results: Prevalence of hysterectomy in this sample was 26.3% (mean age = 37.1). The primary pain type for all women was lumbosacral. Hysterectomy status was not associated with average pain intensity. However, after controlling for age, average pain intensity, anxiety, and depression, hysterectomy significantly predicted opioid use (X2 = 13.23; p = 0.0003); hysterectomy was associated with a three-fold likelihood for opioids (OR 3.29, 95% CI 1.7–6.3).
Conclusions: Independent of pain intensity, hysterectomy is strongly associated with opioid prescription in women being treated for chronic pain. More research is needed to clarify the factors that mediate treatment patterns in this subpopulation.
ZanjaniFaika
(presenting author)
1MartinCatherine2SchoenbergNancy3
Department of Gerontology, University of Kentucky
Department of Psychiatry, University of Kentucky
Department of Behavioral Science, University of Kentucky
The Feasibility of a Mental Health Treatment Engagement Intervention Program in Men and Women
Background and Objective: Mental health disorders are one of the leading causes of disability in women; however, many women do not get necessary treatment. This study is designed to expand the applicability of disease management and motivational interviewing into psychiatric appointment management, to prevent the under-treatment of psychopathology due to failure of treatment engagement. Research has indicated that mail and phone reminders, or appointment scheduling assistance, without motivational components do not effectively improve psychiatric treatment rates. Therefore, this project aims to conduct a trial examining the feasibility of a telephone-based brief motivational intervention as a method for increasing psychiatric treatment rates among both men and women (effectiveness has been seen earlier in men only).
Methods: The study has recruited N = 30 patients (50% women; 37% with depression as chief complaint) with intake appointments at the University of Kentucky Outpatient Psychiatry. Recruited patients are asked to complete baseline and 6-month followup telephone interviews. Patients randomized to receive the intervention participated in a brief telephone motivational interview targeting their barriers and motivation to attending their upcoming psychiatric intake appointment.
Results: Outcomes indicate 92% in the intervention group compared to 57% in the control group attended their intake psychiatric appointment, showing intervention effectiveness (p = 0.037) using chi-square analyses, with no interaction effect for gender.
Conclusions: Results indicate that the proposed intervention is feasible, acceptable, and effective for both men and women within an outpatient psychiatric unit. Engagement in treatment is the first step in ensuring treatment, consequently impacting psychiatric morbidity and mortality.
GhettiChiaraDepartment of Obstetrics, Gynecology, and Reproductive Sciences at Magee-Womens Hospital, University of Pittsburgh
Interrelatedness of Depression and Anxiety in Women With Pelvic Organ Prolapse: Methodological Challenges Encountered Upon Implementing the Study
Background and Objective: Pelvic organ prolapse (POP) affects half of women over the age of 50. While depression is highly prevalent in women with urinary incontinence, little is known about the relationship among POP, major depression, anxiety, and quality of life (QoL). The aims of my proposal are to investigate the interrelatedness of POP, major depression, anxiety, and QoL, and the effects of depression and anxiety on post-treatment outcomes. The objectives of this abstract are to outline study methodology and the challenges encountered upon implementing the study.
Methods: The study design includes cross-sectional and longitudinal components. Quantitative data are collected from new patients via self-administered questionnaires to determine the prevalence of depressive and anxiety symptoms in women who present for evaluation of POP. Two hundred women who proceed to reconstructive surgery and 200 who proceed with conservative management are prospectively followed to investigate the impact of depression and anxiety on outcomes.
Results: Launching the study revealed issues not predicted by protocol alone. Challenges spanned study administration, patient safety, and data collection. These included form creation, tracking of subjects who change treatment plans, depression monitoring, development of a suicidality protocol, and transitioning to electronic data capture. To date, 140 subjects are enrolled in the following groups: baseline only (12), surgical cohort (83), conservative cohort (29), withdrawn (13), and pending group assignment (2).
Conclusions: Numerous methodological challenges were encountered upon initial implementation of the study. The investigator gained new research and problem-solving skills.
BeeberAnna S.Adult and Geriatric Health Department, School of Nursing, University of North Carolina at Chapel Hill
Application of the Family Management Styles Framework (FMSF) to Families Caring for Older Adults with Dementia
Background and Objective: Approximately 4.5 million people in America have dementia, and their progressive decline challenges families as they try to ensure safety, manage challenging behaviors, and make care decisions. Demographically, 75% of family caregivers are women who care for multiple family members. While caregiving has been linked to detrimental outcomes, including a stress, depression, and comorbid disease, the family unit has not been examined within a framework that might guide service improvements for the patient and family. The Family Management Style Framework (FMSF) is well established and used to describe the family response to chronic illness care of children, but not the dementia population. Our objective is to apply the FMSF to families caring for older adults with dementia and identify the family's management style.
Methods: Using data from an existing dataset of daughter caregivers for older adults with dementia, we are examining how families manage care. Transcribed audiotaped interviews with five daughter caregivers are being coded for the FMSF themes and subthemes to identify the family management styles.
Results: The preliminary findings include the caregivers' FMS-related definitions of the situation, management behaviors, and the perceived consequences of the illness, as well as the assessment of the present (thriving, accommodating, enduring, struggling, and floundering). These findings will be used to develop an interview guide for a future qualitative study applying the FMSF to families caring for older dementia patients.
Conclusions: The FMSF could help to tailor long-term care delivery in the hopes of minimizing caregiver burden and improving the quality of life for patients.
Department of Medicine, Brigham and Women's Hospital
Department of Psychiatry, Brigham and Women's Hospital
Department of Radiology, Brigham and Women's Hospital
Department of Medicine, Massachusetts General Hospital
Department of Psychiatry, Massachusetts General Hospital
Harvard Medical School, Massachusetts Institute of Technology
Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology
Stress-Response Circuitry Hypoactivity and Hormonal Dysregulation in Women with Depression
Background and Objective: Major depressive disorder (MDD) is a leading contributor to overall disease burden and is more likely to occur among women than men. Gender differences have been consistently observed, yet remain largely unexplained. Previous research on MDD suggests high rates of endocrine dysfunction and deficits in brain activation in the stress response circuitry (amygdala, hypothalamus, hippocampus, anterior cingulate gyrus [ACC], and orbitofrontal cortex [OFC]). This study was designed to investigate the relationship between HPA- and HPG-axis hormones, and stress response circuitry function in MDD.
Methods: During two points in their menstrual cycles (early follicular [EF], ovulation [OV]), female participants (10 with recurrent MDD, 10 controls) were scanned while viewing IAPS pictures on a 3T GE MR scanner. Baseline hormone measures included pituitary (ACTH), gonadal (estradiol, testosterone), and adrenal (cortisol) hormones.
Results: While adrenal and pituitary hormone levels were similar between groups at EF and OV, the MDD group showed a greater suppression of ACTH at OV compared to EF. Estradiol was greater in controls v. MDD at EF and OV. Controls showed greater activation compared to MDD in the hypothalamus, subgenual ACC, and OFC at both EF and OV, as well as the amygdala and hippocampus at OV.
Conclusions: These results suggest dysregulation of the HPA and HPG axes in MDD, with deficits in stress response regions involved in HPA-axis feedback mechanisms. With additional data on DHEA (produced by the adrenal cortex), future analyses will provide insights into where in the HPA axis these deficits occur.
CorteColleen
(presenting author)
HardyElaineRongmuangDaravanUniversity of Illinois at Chicago
Disparities by Gender and Race/Ethnicity in Risk Factors for Alcohol Problems
Background and Objective: Low-income urban youth are at high risk for alcohol problems, and while boys drink more frequently and more heavily than girls do, girls accelerate to problem alcohol use more quickly than boys do. Specifying the mechanisms underlying these disparities is essential for developing more effective prevention strategies. Our objective is to examine gender and race/ethnicity differences in key risk and protective factors for alcohol misuse in low-income minority urban youth.
Methods: Low-income 9- to 12-year-old Black and Hispanic youths were recruited from schools and summer youth programs in Chicago. Using interview format, participants completed self-report measures of five risk factors (parental alcohol problems, antisocial behavior, negative self-conceptions, presence of an alcohol-specific self-conception, and low self-esteem) and one protective factor (positive self-conceptions). Two-way ANOVAs (race/ethnicity and gender) and chi-squares were used to examine group differences.
Results: The sample consisted of 73 youth (58% Black, 42% Hispanic; 53% girls) with a mean age of 10.7 + 1.1 years. Compared to Hispanic youth, Black youth had lower parental alcohol problems scores (p < 0.05) but had higher antisocial behavior scores (p < 0.01). Boys had higher self-esteem than girls (p < 0.05). No other significant gender or race/ethnicity differences were found and no interactions between gender and race/ethnicity were found.
Conclusions: Black and Hispanic youth had different risk factors, and one risk factor differed for boys and girls. Effective prevention efforts may need to be race/ethnicity-specific and gender-specific. Longitudinal studies are needed to determine the impact of these differences on the onset of drinking and development of alcohol problems in low-income minority adolescents.
Boynton-JarrettRenée D.
(co-presenting author)
1HarvilleEmily W.
(co-presenting author)
2
Division of General Pediatrics, Boston Medical Center and Boston University School of Public Health
Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine
Childhood Adversities and Age at Menarche: Lessons From Post-War Britain
Background and Objective: Psychosocial stressors, including child abuse, paternal absence, and family conflict, are associated with age at menarche, yet pathways are poorly understood. Our objective is to investigate the impact of different forms of childhood adversities on age at menarche (≤12 and ≥14 years).
Methods: The 1958 British Birth Cohort is a prospective longitudinal cohort study (1958–2003). Using a factor analysis methodology, we identified six types of childhood adversities: financial, family dysfunction, lack of interest in education, lack of supportive caregiving, mental health/violence exposure, and family structure challenges. Logistic regression analyses to explore the impact of these six types of childhood adversities on age at menarche (≤12 and ≥14 years) among a subset of 4,524 female participants.
Results: Of the 4,524 female participants, 27% (n = 1,200) experienced menarche at ≥14 years. Cumulative adversities in childhood were associated with a graded increase in risk for later onset menarche (age ≥14) of 24% to 55% among those with 2 to ≥4 adversities. When evaluating individual adversity types, risk for menarche at ≥14 years increased by 19% to 74% for those exposed to financial hardships, lack of interest in education, and family violence/mental health issues. Family dysfunction was associated with decreased odds of menarche at ≥14 years of age (OR = 0.75, 95% CI 0.51–1.09, p = 0.13).
Conclusions: In this prospective cohort study, several categories of childhood adversities were associated with later menarcheal age. A graded association between cumulative adversities and risk for later age at menarche and protection from earlier menarche was demonstrated.
KatzmanWendy B.
(presenting author)
1KadoDeborah2
Department of Physical Therapy and Rehabilitation Science, University of California, San Francisco, Los Angeles
Department of Orthopedic Surgery and Department of Medicine, University of California, Los Angeles
Hyperkyphosis Is Associated With Impaired Mobility Among Older Community-Dwelling Women: The Fracture Intervention Trial (FIT)
Background and Objective: Age-related hyperkyphosis is associated with impaired mobility, but it is not known what degree of hyperkyphosis predicts impairment. To determine the degree of hyperkyphosis associated with impaired mobility, we performed a cross-sectional analysis of 3,222 women ages 55–80 years who were randomized to placebo in the Fracture Intervention Trial (FIT), a randomized controlled trial of the effect of alendronate on risk for osteoporotic fractures.
Methods: Kyphosis angle was measured using the Debrunner kyphometer and was categorized into tertiles. Timed Up-and-Go test, a measure of functional mobility, was dichotomized into normal (=12 seconds) and impaired mobility (>12 seconds). Multivariate logistic regression models (controlling for age, smoking, spine bone mineral density, grip strength, and vertebral fractures) were used to determine cutpoints for kyphosis associated with impaired mobility.
Results: On average, women were 68 years old (SD = 6) with kyphosis angle of 48° (SD = 12°). Women in the third (worst) tertile of kyphosis (=54°) were 40% more likely to have impaired mobility (OR 1.4, 95% CI 1.1–2.0) than those in the first tertile were. Among the 1,048 women in the third tertile of kyphosis, 11% (355) displayed impaired mobility.
Conclusions: Kyphosis angle = 54° is associated with a 40% increased risk of impaired mobility. Hyperkyphosis is an easily identifiable clinical marker and may be a contributing factor to impaired mobility in the elderly.
Center for Healthy Aging, University of California, Davis, School of Medicine
Boston University School of MedicineUniversity of Alabama School of MedicineUniversity of Iowa School of MedicineUniversity of California, San Francisco, School of Medicine
The Association of Parity with Knee Osteoarthritis and Total Knee Replacement in the MOST Cohort
Background and Objective: A recent study found that women's risk of total knee replacement (TKR) increased with each additional birth they had had. Our objective is to evaluate further the association of TKR and parity, and whether osteoarthritis (OA) may mediate this association.
Methods: The Multicenter Osteoarthritis Study (MOST), funded by the National Institutes of Health, is a longitudinal observational study of people ages 50 to 79 either with symptomatic knee OA or at high risk of knee OA. Women were grouped based on their number of children: 0, 1–3 births, and 4 or above. We used Poisson regression to estimate the relative risk of having baseline or incident radiographic knee OA (RKOA) and having prevalent TKR at 30 months. Generalized Estimating Equations were used to account for the correlation between two knees within a woman.
Results: A total of 1,820 women reported parity information (mean age 62.6 years, mean body mass index [BMI] 30.7). After adjusting for BMI and other covariates, compared to those who had no children, women with 1–3 children had a relative risk at 30 months of prevalent TKR of 2.4 (1.2, 4.8), while women with 4–12 children had a relative risk for prevalent TKR of 2.3 (1.1, 4.9). Parity was not significantly associated with baseline or incident RKOA.
Conclusions: Women's parity was associated with prevalent TKR but not with prevalent or incident RKOA. This suggests that the effect of parity on risk of TKR may result from social, neurological, or hormonal factors but not RKOA.
YaoWei
(presenting author)
ChengZhiqiangShahnazariMohammadDaiWeiweiLaneNancy E.Department of Internal Medicine, Center for Healthy Aging, University of California, Davis, School of Medicine
Augmentation of Peak Bone Mass by Inhibiting Progesterone Nuclear Receptors
Background and Objective: Osteoporosis is a significant cause of morbidity and mortality in women as they age. Augmentation of peak bone mass (PBM) is the most significant way to reduce the risk of developing osteoporosis later in life. However, no effective treatments are currently known that increase PBM. Our objective is to characterize bone mass acquisition and bone metabolism in progesterone receptor knock out (PRKO) mice compared to wild type (WT) controls.
Methods: We compared PRKO mice to WT controls for bone mass and bone turnover markers in vivo from ages 1 to 9 months. Osteogenesis and osteoclastogenesis were measured at 3 months of age when PBM was achieved. A group of WT females was also treated with a progesterone nuclear receptor antagonist, RU486 (500μg/mice, 3 × /week), from 1 to 3 months of age. Bone mass and bone turnover were measured by microCT, bone histomorphometry, and biochemical turnover markers.
Results: We demonstrated significantly higher PBM in PRKO mice or with a PR antagonist treatment (p < 0.05). Compared to their WT littermates, PRKO mice developed significantly higher PBM by 3 months of age in both sexes (>100%); this was associated with increased cell osteogenesis, in vivo bone formation, and lowered bone resorption. RU486 treatment in weaning WT mice induced similar changes to those in PRKOs.
Conclusions: Our results suggest that the inhibition of PR during rapid bone growth induces an uncoupling of bone turnover, greatly augmenting PBM. Our findings provide a novel application of anti-PR treatment to augment PBM and reduce the burden of osteoporosis.
StensonAmy L.
(presenting author)
Michael ChenaKuang-YuiSantiskulvongaChintdaKaramaAmerMoatamedbNedaRaobJianYuFarias-EisneraRobinDorigoaOliver
(presenting author)
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, and Department of Pathology, David Geffen School of Medicine, University of California, Los Angeles
Identification of Molecular Targets in Paget's Disease of the Vulva (PDV)
Background and Objective: Paget's disease of the vulva (PDV) is a rare and poorly understood disease with limited treatment options. Identification of improved therapy, particularly for severe, recurrent disease, is critically needed. Recent studies have demonstrated inconsistent overexpression of HER2neu, while little is known about other potential therapeutic targets such as the epidermal growth factor receptor (EGFR) family or the PI3 kinase pathway (PI3K). Our objective is to evaluate the clinical characteristics and molecular expression patterns for HER2, EGFR, and PI3K in PDV.
Methods: The University of California, Los Angeles, department of pathology database was queried to identify patients with PDV. Demographic data were collected retrospectively. Immunohistochemistry was performed for HER2neu, EGFR, pAKT, pS6, and PTEN, and results were summarized. A subset analysis was performed for patients with recurrent disease or a personal/family history of cancer.
Results: We identified 17 patients with PDV from 1995 to 2007. Median age was 65 years. Ten patients (59%) had documented recurrence. Six patients (35%) had a personal history of cancer, while eight (47%) had a family history of cancer. HER2 overexpression was demonstrated in 11 (65%) and EGFR in seven (41%). Activation of the PI3K was suggested: pAKT expression was demonstrated in 15 (88%), pS6 in 15 (88%), and PTEN in 10 (59%).
Conclusions: Demographics were similar to previous reports, though recurrence and associated cancer were higher. Expression patterns suggest that HER2, EGFR, and the PI3K pathway may play an important role in the pathogenesis of PDV. Specific therapy targeting the EGFR family or PI3K may prove effective and warrants investigation.
HinchcliffMonique E.
(presenting author)
1CarnsMary1PodluskySofia1KiefferNicole2VargaJohn1
Rheumatology Division, The Feinberg School of Medicine, Northwestern University
Department of Internal Medicine, North Shore University Health System
The Establishment of a Systemic Sclerosis Patient Registry: Lessons Learned
Background and Objective: Systemic sclerosis (SSc)/scleroderma is a rare disease that primarily affects women. The pathogenesis involves vasculopathy (Raynaud phenomenon), autoimmunity (autoantibody production), and fibrosis (internal organ dysfunction). SSc patients are an extraordinarily heterogeneous patient population demonstrating various clinical manifestations, rates of disease progression, patterns of internal organ involvement, response to treatment, and prognoses. Our objective is to define hitherto clinically indistinguishable subsets of SSc patients using clinical information as well as serum, DNA, and RNA assays for enrollment in SSc biomedical research projects.
Methods: We enroll consecutive SSc patients who fulfilled American College of Rheumatology criteria for diagnosis. Patients complete demographics forms and a detailed medication history, as well as health-related quality of life questionnaires. Patients may donate blood for serum collection and DNA isolation and tissue samples for RNA analyses. Standardized clinical assessments are completed by one of two scleroderma specialists. Evaluations include standardized laboratory and diagnostic testing (Doppler echocardiography, high-resolution computerized tomography of the chest, and pulmonary function testing). All information is stored in a state-of-the-art central data repository (EDW) that can be easily queried.
Results: DNA samples have been collected on 300/400 (75%) patients since March 2005: only 36 patients have declined. Since February 2009, 85 patients have enrolled in our registry and biorepository; only four patients have declined.
Conclusions: SSc patients seen at our tertiary care center are enrolling in our patient registry and biorepository. Physician and patient time constraints limit enrollment that necessitates collection/completion of separate components of the registry at separate clinic visits.
Department of Therapeutic Radiology, University of Minnesota Medical School
Department of Radiology, University of Minnesota Medical School
Department of Biostatistics, University of Minnesota Medical School
Department of Medicine, University of Minnesota Medical School
Department of Obstetrics and Gynecology, University of Minnesota Medical School
Longitudinal Assessment of Bone Health in Gynecologic Oncology Patients: The Roles of Chemotherapy and Radiation
Background and Objective: Gynecologic cancer patients undergoing treatment combination of oophorectomy, chemotherapy, and radiation are at high risk for osteoporotic fracture leading to increased morbidities and reduced quality of life. Our objective is to evaluate the longitudinal changes of volumetric bone mineral density (vBMD) using quantitative computed tomography (QCT) in gynecologic cancer patients undergoing anticancer therapy.
Methods: Serial CT scans (pre- and post-treatment) were analyzed for vBMD in trabecular spine and the femoral neck. General linear mixed models were used to analyze the percentage vBMD loss for age, treatment, bone sites, scan interval, and their interactions.
Results: We evaluated 12 ovarian, 15 endometrial, and 18 cervical cancer patients. Mean age (±SD) was 65.1 (±11.6), 60.3 (±7.8), and 49.7 (±10.8), respectively. There was significant decrease in mean vBMD immediately after treatment (13.7% ± 20.3%, p < 0.0001), which continued to decrease for up to 1 year (12.0% ± 40.0%, p = 0.0003). Ovarian, endometrial, and cervical cancer patients lost mean vBMD (±SD) at the L1-L2 by 12.8% (±11.0%), −0.3% (±11.2%), and 14.2% (±9.9%) immediately after treatment; 15.9% (±19.6%), 5.2% (±20.5%), and 21.0% (±19.9%) after 1 year and at the femoral neck by 10.3% (±7.1%), 7.4% (±17.8%), and 10.2% (±13.8%) immediately after treatment; by 10.4% (±14.1%), 4.3% (±25.6%), and 3.6% (±9.5%), respectively, after 1 year. The mean vBMD decrease was greater at sites within the radiation treatment field than sites outside of the treatment field.
Conclusions: Significant bone loss in patients with gynecological cancers after chemotherapy or radiation treatment underlines the importance of monitoring treatment-induced bone loss and investigating preventive therapy.
Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine
Shanghai Cancer Institute, Shanghai
Resting Heart Rate and Risk of Type 2 Diabetes in Women
Background and Objective: Autonomic dysfunction may be involved in the pathogenesis of insulin resistance and the metabolic syndrome. Whether simple measures of autonomic activity, such as resting heart rate, may predict risk of type 2 diabetes (T2D) remains unclear. Our objective is to evaluate the association between resting heart rate and risk of T2D in the Shanghai Women's Health Study, a population-based prospective cohort study.
Methods: This analysis included 47,571 women without prior history of diabetes, cancer, cardiovascular disease, or thyroid dysfunction at the time when resting heart rate was measured. T2D was defined according to the American Diabetes Association criteria.
Results: During a mean followup of 4.9 years, 849 women developed T2D. Resting heart rate was positively and significantly associated with T2D risk. After adjustment for physical activity and other potential confounders, the hazard ratios (95% CIs) for T2D across increasing quintiles of heart rate were 1, 1.21 (0.99–1.47), 1.31 (1.05–1.62), 1.38 (1.12–1.70), and 1.61 (1.28–2.01), respectively. Further analyses of joint effects of heart rate with body mass index (BMI), waist-hip ratio (WHR), or blood pressure (BP) showed increased risk of T2D with increasing heart rate in all categories of BMI, WHR, or BP. Women in the highest category of heart rate plus highest category of BMI, WHR, or BP had the highest hazard ratios of T2D, ranging from 4.81 to 6.37.
Conclusions: A high resting heart rate is independently associated with an increased risk of T2D in women. The combination of heart rate with BMI, WHR, or BP improves T2D risk prediction.
WilliamsKaren J.
(presenting author)
TempleJeff R.BerensonAbbey B.Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston
Weight Loss Experiences among Prenatal and Postpartum Hispanic Women
Background and Objective: The proportion of U.S. pregnant women exceeding the Institute of Medicine's recommendations for gestational weight gain is 46%. Excess gestational weight gain leads to increases in excess postpartum weight retention, which leads to chronic disease. Evaluations of the effect of diet, exercise, or both for postpartum weight reduction indicate that diet alone or diet plus exercise are effective over usual care. Women from racial and ethnic minorities have higher rates of obesity and excess gestational weight gain. However, little is known about the preferences of these groups for postpartum weight loss programs, especially for Hispanic women, the U.S. population group with the highest population growth and birthrate. Our objectives were to (1) determine experience with overall weight loss and weight loss after delivery, and (2) develop effective weight loss strategies for postpartum women, emphasizing the experiences of Hispanics.
Methods: Semi-structured interviews and chart reviews were conducted among 100 women in prenatal clinics. Data were coded by themes, entered into SPSS, and analyzed using descriptive statistics.
Results: Of the respondents, 89% were Hispanic women. The most desired program components included (1) group exercise, (2) exercise only, and (3) a combination of diet and exercise. Women indicated payment for participation would not increase their participation, while free mental health counseling or therapy would.
Conclusions: Weight loss interventions for Hispanic women should include a combination of diet and exercise, and (1) free mental health counseling and (2) group settings for learning about and engaging in changes in physical activity and nutrition.
FriscoMichelle L.
(presenting author)
1WedenMargaret2
Department of Sociology, Pennsylvania State University
The RAND Corporation, Pittsburgh
Adolescent Obesity and Life Course Childbearing
Background and Objective: Obesity is negatively associated with a wide range of fertility outcomes among adult women, but research has not considered whether obesity has the same implications for adolescent women's childbearing experiences. Obese adolescent girls are less likely than non-obese adolescent girls to have sexual intercourse, but when they do have sex, obese adolescent girls are more likely than their non-obese counterparts to participate in high risk sexual behaviors that increase their risk of unintended pregnancy. Furthermore, fecundity is quite high in the teen years. The authors examined obese adolescent girls' risk of nonmarital pregnancy, timing of their first birth, and total number of children born by the end of their reproductive years. We hypothesize that adolescent obesity will be positively related to each childbearing outcome.
Methods: Twenty-five years of data from National Longitudinal Survey of Youth: 1979 (NLSY:79) on female respondents ages 16–19 in 1981 (n = 1,745) were analyzed to study hypotheses using descriptive statistics, logistic regression methods, and event history methods. Multivariate models adjusted for important confounders including poverty status and girls' race/ethnicity.
Results: Obese adolescent girls were found to have earlier first births and more total births than their non-obese counterparts in both descriptive and multivariate analyses.
Conclusions: Results suggest that scholars cannot assume that obesity has the same consequences for childbearing across the women's reproductive years. Instead, they must keep in mind that neither the consequences of weight nor women's reproductive capacity is static.
Raja-KhanNazia
(presenting author)
1KunselmanAllen1SpielmanRichard2LegroRichard1
Pennsylvania State University College of Medicine
University of Pennsylvania School of Medicine
TGF-β Dysregulation in Women with Polycystic Ovary Syndrome
Background and Objective: Polycystic Ovary Syndrome (PCOS) and TGF-β dysregulation have been individually associated with reproductive dysfunction, altered glucose metabolism, renin-angiotensin system (RAS) hyperactivity, and cardiovascular dysfunction. In addition, PCOS has been linked to Allele 8 (A8) of D19S884, a dinucleotide repeat in an intron of the fibrillin-3 gene. The fibrillins are extracellular matrix proteins that regulate TGF-β activity. Therefore, TGF-β dysregulation may play a central role in the pathogenesis of PCOS, particularly in the presence of A8. The objective of this study was to determine if circulating TGF-β levels are altered and associated with the presence of A8, RAS hyperactivity, and abnormal glucose metabolism in women with PCOS.
Methods: We measured circulating TGF-β levels and other hormonal and metabolic parameters in 120 age-matched women, including 40 PCOS women who possess A8 (A8+ PCOS), 40 PCOS women who do not possess A8 (A8- PCOS), and 40 normally menstruating women who do not have PCOS or A8 (A8- Controls).
Results: Compared with A8- Controls, A8- PCOS is associated with significantly higher TGF-β1 and lower TGF-β2, adjusting for BMI. Compared with A8- PCOS, A8+ PCOS is associated with significantly lower TGF-β1, similar TGF-β2, significantly higher aldosterone and Inhibin B, and a nonsignificant trend toward lower fasting glucose to insulin ratio, adjusting for BMI.
Conclusions: Among women with PCOS, A8 positivity may contribute to dysregulation of TGF-β1, increased RAS activity, altered glucose metabolism, and possibly reproductive dysfunction due to significantly higher Inhibin B levels. TGF-β2 levels are reduced in PCOS, regardless of A8 status.
Miller-HughesStephania T.Meharry Medical College
Diabetes-Related Distress Improved Among African-American Women with Type 2 Diabetes Following a Pilot Dietary and Physical Activity Intervention
Background and Objective: Diabetes-related distress (DRD) is associated with poorer glycemic control among adults with diabetes. We assessed whether adding motivational interviewing (MI), a patient-centered behavioral counseling style, enhanced improvement in DRD among African-American women with type 2 diabetes participating in a group dietary and physical activity intervention (group behavioral intervention).
Methods: Participants, African-American women ages 21–60 who had diabetes more than 6 months and were not insulin dependent, were assigned to either a 6-week group behavioral intervention (Non-MI Group) or the same plus individual MI sessions (MI Group). DRD was measured at baseline, 3, 6, and 24 weeks (followup) using a validated self-report measure of DRD, the Problem Areas in Diabetes (PAID) survey. DRD scores range from 0 (no DRD) to 100 (severe DRD).
Results: For MI participants (n = 7), DRD scores improved throughout the intervention but were not sustained at followup (baseline: 34.29 ± 27.33; 3 weeks: 20.00 ± 12.87; 6 weeks: 7.81 ± 5.98; 24 weeks: 22.50 ± 11.90). For Non-MI patients (n = 6), intervention improvements were enhanced at followup (baseline: 29.58 ± 27.50; 3 weeks: 17.50 ± 20.04; 6 weeks: 17.25 ± 21.62; 24 weeks: 4.38 ± 7.18).
Conclusions: DRD improved for all patients during the intervention. The addition of MI to the group behavioral intervention provided no benefit beyond the active intervention period. Given the small sample size for this study, a larger patient sample is needed to validate these findings and to assess potential mediators of change in DRD between MI and Non-MI patients.
SchauerIrene E.
(presenting author)
HerlacheLeah L.RegensteinerJudith G.ReuschJane E. B.University of Colorado, Denver
Induction of Insulin Resistance by Acute Fatty Acid Elevation Partially Recapitulates Exercise Defects Seen in Diabetes
Background and Objective: Physical fitness correlates inversely with cardiovascular and all cause mortality. Defects in functional exercise capacity, manifested by decreased peak oxygen consumption (peak VO2) and slowed VO2 kinetics, have been demonstrated in individuals with type 2 diabetes (T2D) or insulin resistance (IR), but the mechanism remains unknown. Serum non-esterified fatty acid (NEFA) elevation by lipid/heparin infusion induces IR in healthy adults. We hypothesized that NEFA elevation comparable to that seen in diabetes may recapitulate the exercise defects of T2D. Targeting NEFA levels in diabetes could therefore potentially improve exercise capacity.
Methods: Seventeen lean adults (53% female, age 30 ± 6 years) with normal fasting glucose, HbA1c, and glucose tolerance, and no family history of T2D were studied. Insulin sensitivity was measured by hyperinsulinemic euglycemic clamp and exercise capacity by cycle ergometry with a metabolic cart. Subjects were studied after 6 hours of liposyn/heparin infusion v. saline infusion.
Results: Initial liposyn/heparin infusion resulted in NEFA levels of 2–3mM, and the infusion rate was reduced for the remaining subjects, resulting in a mean 6-hour NEFA level of 1.08 ± 0.22 mM. Insulin sensitivity was impaired by NEFA elevation (glucose infusion rate: 6.57 ± 2.25 v. 8.50 ± 2.72, p = 0.0002). Peak VO2 was not affected (31.37 ± 5.54 v. 31.29±5.54, p = 0.92), but VO2 kinetics were significantly slowed (tau2: 34.7 ± 12 v. 29.9 ± 9 sec, p = 0.023), suggesting a slower physiological adjustment to exercise.
Conclusions: NEFA elevation in nondiabetic individuals induces IR and recapitulates the slowing of VO2 kinetics seen in T2D. This finding may help explain the exercise abnormalities observed in T2D and suggest targeted treatment options.
Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center
Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center
Utilizing Ecological Momentary Assessment in Adolescents With Polycystic Ovary Syndrome To Quantify Behavior, Emotion, and Sleep
Background and Objective: This study examined the feasibility of using Ecological Momentary Assessment (EMA) to examine important domains relevant to interregulatory health processes in overweight adolescent females with Polycystic Ovary Syndrome (PCOS).
Methods: Participants were 20 overweight adolescent females engaged in a cognitive-behavioral and motivational interviewing intervention aimed at weight loss and improving mood (11–19 years old, 80% Caucasian, 15% African-American, mean BMI = 39). During this EMA protocol, participants were asked to report their physical activity (PA), nutrition, mood, and sleep during 14 cellular phone calls in their natural environment over three extended weekends (Thursday to Monday). Simultaneously, participants wore an actigraph (armband watch communicator) that provided instantaneous PA feedback (steps taken and kilocalories) and sleep parameters (duration and efficiency).
Results: EMA compliance rates for the armband and phone calls were 74.7% ± 0.3 and 64.2% ± 0.3, respectively. A positive association existed between baseline depression and armband compliance (Rho = 0.50, p = 0.03), but not phone call compliance (Rho = −0.26, p = 0.26). No relation was found between sleep problems and EMA compliance; a positive association existed between baseline measures of breathing regularity during sleep and armband compliance (Rho = 0.44, p = 0.052). No associations existed between baseline BMI and armband compliance (p = 0.99) or phone call compliance (p = 0.24).
Conclusions: Data from the armband and phone calls are presented to illustrate the depth of information acquired by utilizing this innovative methodology. These data reveal that nutrition, physical activity, mood, and sleep can be objectively measured simultaneously to enhance comprehensive treatment of overweight adolescents.
Department of Preventive Medicine and Public Health, University of Kansas Medical Center
Department of Dietetics and Nutrition, University of Kansas Medical Center
Schiefelbusch Institute for Life Span Studies, University of Kansas
Phone-Based Weight Management for Rural Women
Background and Objective: Rural women have among the highest rates of obesity and sedentary lifestyle, yet few studies have examined strategies for delivering state-of-the-art obesity treatment to hard-to-reach rural areas. Phone-based treatment appears to be the best alternative to traditional face-to-face group meetings for rural populations of whom only half have home Internet access and where tele-video capacity is limited to a few sites. The purpose of this randomized study was to examine the impact and cost-effectiveness of a 6-month behavioral weight loss program delivered to rural women by phone, either one-on-one with a counselor or to a group via conference call.
Methods: Thirty-four rural women (mean BMI = 34.4, SD = 4.6) were randomized to group phone-based treatment or individual phone-based treatment.
Results: Completers analysis showed that weight loss was greater in the group condition (mean = 14.9 kgs, SD = 4.4) compared with the individual condition (mean = 9.5 kgs, SD = 5.2; p = 0.03). Among the total sample, 62% of participants in the group condition achieved the 10% weight loss goal compared to 50% in the individual condition. Group treatment was found to be more cost effective; using the percentage of participants who achieved 10% weight loss in intent-to-treat analysis, cost-effectiveness from a program plus participant perspective (average cost per successful participant was $714 for group counseling and $1029 for individual counseling).
Conclusions: Future research is warranted to examine the benefits of group phone-based treatment for long-term management of obesity among rural populations.
Oncology Division, University of Kansas Cancer Center
Department of Preventive Medicine, University of Kansas Medical Center
Department of Biostatistics, University of Kansas Medical Center
Feasibility of a Diet, Exercise, and Behavior Modification Intervention for Post-Menopausal Breast Cancer Survivors
Background and Objective: Obesity is prevalent in general population and among breast cancer (BrCa) survivors. Weight at diagnosis and weight gain post-diagnosis are associated with increased risk of BrCa recurrence and mortality. Regular exercise also reduces the risk of dying from BrCa. This study was conducted to determine the feasibility of a structured diet/exercise/behavioral intervention to achieve a weight loss of >5%, and the effect of participation on serum biomarkers of BrCa and measures of overall health/fitness.
Methods: Subjects in this prospective pilot study are overweight (BMI > 25) female BrCa survivors. The 6-month combined modality diet/exercise/behavior modification intervention included 225 minutes per week of cardiovascular exercise plus resistance training; a 1,200–1,500 calories-per-day diet, including pre-packaged meals and low-calorie shakes; and a weekly in-person group behavioral meeting. Women were recruited into four cohorts of 10 to 15 (n = 50). Participants underwent pre- and post-intervention assessments: anthropometric measures, serum biomarkers, fitness test, and questionnaires to assess food frequency, fatigue, and quality of life.
Results: Women were successfully recruited and participated in the 6-month intervention. More than 95% of participants met the 5% weight loss goal at 6-months, and a majority of women reached an average weight loss of >10%. Mean age was 50, and time from diagnosis to on-study was about 45 months. A total of 85% of the women received adjuvant or neo-adjuvant chemotherapy, and 75% either were currently or had previously taken antihormonal therapy.
Conclusions: A 6-month diet/exercise/behavior modification intervention program is feasible and results in significant weight loss and percent body fat among overweight BrCa survivors.
Department of Family Medicine and Community Health, University of Minnesota Medical School
Department of Biostatistics, University of Minnesota
Department of Epidemiology and Community Health, University of Minnesota
Parenting Style as a Predictor of Adolescent Weight and Weight-Related Behaviors: The Importance of the Opposite Sex Parent
Background and Objective: Current research indicates that specific parenting styles (authoritative, authoritarian, permissive neglectful) are associated with adolescent overweight, dietary intake, and physical activity, but the majority of research has been cross-sectional, making it difficult to determine the temporal order of these associations. Our objective is to (1) identify risk and protective factors of parenting style on adolescent weight status, dietary intake, and physical activity longitudinally; and (2) examine effects of gender differences between opposite-sex and same-sex parent-adolescent dyads.
Methods: Data from Project EAT, a population-based study with diverse ethnic and socioeconomic adolescents were used. Adolescents (N = 2,516) from 31 Minnesota schools completed in-class assessments in 1999 (Time 1) and mailed surveys in 2004 (Time 2). Multiple linear regression models were used to predict mean levels of adolescent outcomes at Time 2 from parenting style at Time 1.
Results: Maternal authoritative parenting style predicted lower BMI in sons and daughters compared to authoritarian and neglectful parenting styles. Paternal permissive parenting style predicted more fruits and vegetables intake in daughters compared to paternal authoritarian parenting style. We did not find significant associations between parenting style and adolescent physical activity.
Conclusions: Findings suggest that authoritative parenting style may play a protective role related to adolescent overweight and that the dimension of warmth and caring in the parent-adolescent relationship may be important in connection to adolescent healthy dietary intake. Further, several significant adolescent health outcomes were gender-specific to opposite-sex parent-adolescent dyads. This gender pairing may hold important information related to assessing and intervening with adolescent obesity.
HollidayMichael J.1GroveKevin L.2McCurdyCarrie E.
(presenting author)
1
Department of Pediatrics, University of Colorado, Denve
Division of Neurology, Oregon National Primate Research Center, Oregon Health and Sciences University
Exposure to Maternal Obesity Does Not Reduce Mitochondrial Biogenesis or Complex Stoichiometry in Fetal Skeletal Muscle of Japanese Macaques
Background and Objective: Maternal obesity is associated with increased risk and earlier onset of obesity and type-2 diabetes (DM2) in the offspring, linking the fetal environment to adult susceptibility to metabolic diseases. Reduced mitochondrial density and impaired function have been observed in lean adult offspring of DM2 with insulin resistance, suggesting that these defects may begin during fetal development. Using a nonhuman primate model, we investigated whether intrauterine exposure to maternal obesity decreases fetal mitochondrial biogenesis and function in skeletal muscle.
Methods: Female Japanese macaques were fed either a control (10% fat) or a high-fat/calorie diet (35% fat; HFD) for 2–4 years. Skeletal muscle was collected from fetuses (F-CON/F-HFD) terminated early in the third-trimester from control and HFD mothers. Muscle gene expression was analyzed by DNA microarray and proteins involved in mitochondrial biogenesis and metabolic function confirmed by real-time PCR or immunoblot analysis.
Results: Skeletal muscle from F-HFD accumulated significantly more triglycerides with no difference in key regulators of lipid metabolism (ACC, ppar-a, ppar-γ). F-HFD muscle had increased expression of inflammatory/apoptotic pathways and reductions in MAPK-growth pathways, which was associated with smaller fetal weight (5–10%). However, no decrease was found in mitochondrial protein abundance, complex stoichiometry, or transcription factor expression (PGC1a, SIRT1/3) in F-HFD.
Conclusions: Intrauterine exposure to maternal obesity does not reduce skeletal muscle mitochondrial biogenesis or upregulate fat metabolism, despite increased intramuscular lipid and inflammation. Early fetal exposure to elevated lipids, prior to development of adipose depots, may later predispose offspring to impaired muscle fat utilization and insulin resistance.
Division of Rehabilitation Sciences, The University of Texas Medical Branch at Galveston
Sealy Center on Aging, The University of Texas Medical Branch at Galveston
Preventive Medicine and Community Health, The University of Texas Medical Branch at Galveston
Gender Differences in Obesity and Life-Space Mobility among Older Mexican-Americans
Background and Objective: Obesity is a major public health problem associated with reduced mobility in older adults. Our objective is to examine gender differences between obesity (BMI = 30 Kg/m2) at baseline and life-space assessment (LSA) mobility at a 2-year followup among older Mexican-Americans.
Methods: A 2-year prospective study included Mexican-American men and women above age 75 and residing in five southwestern States. Data were collected on sociodemographic variables, physical function, medical conditions, BMI, health-related quality of life (HRQoL), and the LSA instrument that assessed the range, independency, and frequency of movement in the past 4 weeks preceding the interview in person.
Results: Out of 472 subjects, 30.6% of women and 16.7% of men had a BMI = 30 kg/m2 at baseline. The mean score for the LSA instrument was 31.4 (SD = 20.3) in obese women and 40.7 (SD = 17.9) in obese men. Multiple regression analysis yielded a significant gender by obesity interaction effect (β = −8.34, p =0.03) on LSA mobility. Analysis stratified by gender showed the association between obesity and the LSA mobility in women (β = −5.96, p = 0.008) was partially mediated by physical function, HRQoL, and medical conditions. No association was found between obesity and LSA mobility in men.
Conclusions: The association between obesity and lower life-space mobility differed by sex in older Mexican-Americans. Among women, obesity maintained a negative and independent association with life-space mobility in models controlling for other factors that can influence mobility patterns. Conversely, obesity does not seem to affect mobility patterns of men.
JeongHyunyoung
(presenting author)
1KohKwihye1ChoiSuyoung2YangKyunghee1
Department of Pharmacy Practice, University of Illinois at Chicago
Center for Pharmaceutical Biotechnology, College of Pharmacy, University of Illinois at Chicago
Hormonal Regulation of Hepatic Drug-Metabolizing Enzymes
Background and Objective: Medication use during pregnancy is prevalent. Pregnancy influences the rate and extent of hepatic drug metabolism, often leading to changes in dosage regimens. The underlying mechanisms remain unknown. Potentially, estrogen and progesterone, which increase in pregnancy, are responsible for the changes. Our objective is to determine the effects of estradiol and progesterone on expression of major drug-metabolizing enzymes in human hepatocytes.
Methods: Human hepatocytes were treated with ethanol, estradiol, or progesterone for 60 hours. mRNA expression levels of cytochrome P450 (CYP) enzymes (CYP1A2, −2A6, −2B6, −2C9, −2C19, −2D6, −2E1, and −3A4) were determined by quantitative real-time polymerase chain reaction. After estradiol treatment, activities of CYP2B6, −2C9, −2C19, −2D6, and −3A4 were determined in human hepatocytes by performing functionality assays using a set of probe drugs.
Results: Estradiol treatment of human hepatocytes significantly decreased mRNA levels of CYP1A2 and increased mRNA expression of CYP2A6 and −2B6. The estradiol-mediated changes in mRNA expression of other CYP enzymes were not significant. Activities of CYP2B6, −2C9, and −3A4 were significantly increased by estradiol, whereas activities of other CYP enzymes were not affected. Progesterone significantly increased mRNA expression of CYP2A6, −2B6, and −3A4.
Conclusions: The pattern of hormone-mediated changes in expression or activity of most CYPs in human hepatocytes was similar to changes occurring during pregnancy. This suggests that estrogen and progesterone may be responsible for altered drug metabolism in pregnancy. These findings should help us determine optimal drug dosage regimens through a better understanding of how drug metabolism is altered in pregnancy.
ElavskySteriani
(presenting author)
WilliamsNancyMolenaarPeterGoldCarolPennsylvania State University
Person-Specific Correlates of Menopausal Hot Flashes: A Preliminary Report
Background and Objective: Menopausal hot flashes (HFs) are often experienced as distressful and disruptive to daily life, but great individual differences exist in the way women experience and report these symptoms, contributing to diagnostic and treatment conundrums. This study applied experience sampling methods and time-series modeling techniques to investigate person-specific correlates of self-reported menopausal HFs as part of a prospective daily diary study.
Methods: Twenty-four symptomatic middle-aged women completed fitness, body composition, and hormonal status screening, and reported on daily HFs, positive and negative affect, stress, and sleep using an electronic PDA device for 30 days. Daily physical activity was measured using accelerometry, and women provided daily urine samples to assess the analytes of estradiol (E1G) and progesterone (PdG).
Results: A preliminary time-series analysis of data from eight subjects revealed significant cross-lagged effects of daily perceived stress, negative affect, sleep, and PdG on HF frequency in four out of eight subjects; significant cross-lagged effects of daily hassles and E1G on HF frequency in three; and significant cross-lagged effects of physical activity in two out of eight subjects. That is, daily levels of these outcomes on a previous occasion predicted self-reported HF frequency at a following time-point in these subjects. However, the direction of the relationships varied across subjects.
Conclusions: Individual variation in HF reporting patterns may be partially explained by day-to-day changes in measures of stress, affect, sleep, physical activity, and hormonal status. The contribution of other individual or contextual factors and their implication for individualization of treatment options remains to be determined.
Department of Medical Microbiology and Immunology, University of California, Davis
Department of Obstetrics and Gynecology, University of California, DavisKaiser Permanente Medical Group, Sacramento
Internal Medicine, University of California, Davis
Effects of Aging and Menopause on Gut-Associated Lymphoid Tissue
Background and Objective: About 15.4 million women are living with Human Immunodeficiency Virus (HIV) infection worldwide. HIV infection results in the loss of CD4+ T cells in the peripheral blood and gut-associated lymphoid tissue (GALT). HIV disease progression correlates with immune activation. A growing proportion of HIV-infected women are now over 50 years old. The effects of aging and menopause on GALT are unknown. With chronic inflammation, such as HIV infection, the pathogenic effects of HIV may be exacerbated during the course of aging and menopause, as low-grade systemic inflammation is associated with both of these conditions. Our objective is to compare the effects of gender and menopause on cellular activation and inflammation in GALT of HIV negative individuals.
Methods: We evaluated peripheral blood and mucosal T lymphocyte subsets in HIV negative participants using Flow Cytometry. Gene expression profiles in GALT in male (21–57 years) and female (23–59 years) volunteers were analyzed using microarray technology, real-time PCR, and Robust Multi-Chip-based statistical criteria.
Results: Postmenopausal women (n = 3) had higher percentages (18–48% v. 2.5–5%) of activated CD4+ and CD8+ T cells in blood and GALT compared to premenopausal women (n = 3) and men (n = 6). We observed greater than a twofold increase in gene expression associated with inflammation (IL6, iNOS2A, Catalase) and T cell activation (NFAT3, STAT3, IL2, IL12) in postmenopausal women compared to premenopausal women and age-matched men.
Conclusions: Menopause in women may be associated with increased immune activation, providing the foundation for investigation of the independent effects of menopause on HIV pathogenesis.
Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago
University of Illinois at Chicago/National Institutes of Health Center for Botanical Dietary Supplements Research, Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago
Evaluation of Phytoprogestins in Botanical Extracts
Background and Objective: Menopausal women are consuming botanical supplements for the alleviation of hot flashes. Estrogen-like compounds in botanicals used to treat menopausal symptoms might increase the risk for developing endometrial cancer similar to standard estrogens. Progesterone is known to prevent estrogen-induced uterine cancer and is typically combined with estrogen in hormone replacement therapies. Our objective is to determine if plant extracts commonly used to treat menopausal symptoms contain novel progestins that might be used in combination with plant-based estrogens.
Methods: Eight botanical extracts (75% ethanolic) were tested for their ability to induce a luciferase reporter gene driven by the progesterone responsive element promoter. Botanical extracts were then investigated to determine if they could displace fluorescently labeled progesterone from the receptor-binding pocket of the progesterone receptor. Progesterone-regulated gene induction from endogenous promoters was investigated with quantitative real-time PCR.
Results: A 75%-ethanolic extract of red clover bound to the progesterone receptor and significantly induced a luciferase reporter gene linked to the progesterone responsive element in breast cancer cells. The red clover extract also significantly induced endogenous genes regulated by progestins measured using real-time PCR. A library of compounds previously identified in red clover was screened, and two flavonoids, kaempferol and naringenin, were found with a high affinity for the progesterone receptor. Future work will confirm if kaempferol and naringenin have progesterone-like activity in animal models.
Conclusions: Red clover contains phytoprogestins that might protect against endometrial cancers or provide a safer progestin for applications in women's health.
WuWendy W.Department of Obstetrics and Gynecology, Oregon Health & Science University
Estrogen Regulates Input-Output Function of Hippocampal CA1 Pyramidal Neurons
Background and Objective: Hippocampal processing is affected by cyclic fluctuations and pharmacological manipulations of estrogen level. The effect of estrogen on hippocampal function most likely reflects the regulation of communication between hippocampal neurons by estrogen. Neuronal communication is a multistep process involving presynaptic release of neurotransmitters, activation of postsynaptic receptors to change membrane potential, and integration of synchronized synaptic input signals to generate an output command in the form of action potentials. Our objective is to evaluate the effects of estrogen on input-output function of CA1 pyramidal neurons, the major output neurons of the hippocampus.
Methods: Whole-cell patch clamp recordings were performed on CA1 pyramidal neurons from young adult ovariectomized female rats to evaluate excitatory synaptic transmission across the hippocampal Shaffer collateral-CA1 (SC-CA1) synapses and the propensity of CA1 pyramidal neurons to generate action potentials in response to somatic current injection to mimic synaptic inputs; first in control solution followed by bath application of estrogen.
Results: Bath application of estrogen did not affect presynaptic release probability of glutamate at the SC-CA1 synapses. However, estrogen significantly enhanced the postsynaptic membrane response to synaptic stimulation. Further and independent of its effect on input function, estrogen significantly increased the propensity of CA1 pyramidal neurons to generate action potentials in response to somatic current injection.
Conclusions: Estrogen rapidly enhances information transfer across the hippocampus by acting on postsynaptic cellular targets present on CA1 pyramidal neurons to increase the input-output function across the hippocampal CA1 region.
GillJohn C.
(presenting author)
12WangOulu3MajzoubJoseph A.3KaiserUrsula B.12
Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Harvard Medical School
Harvard Reproductive Endocrine Sciences Center
Division of Endocrinology, Children's Hospital Boston
Critical Requirements of Reproductive Hormones for Proper Organization and Activation of the Hypothalamic Kisspeptin System: Evidence From GnRH-Deficient hpg Mice
Background and Objective: Women-specific health concerns indicate that critical periods during sexual differentiation can affect lifelong fitness. The neuropeptide kisspeptin potently stimulates GnRH release, influencing sexual differentiation, puberty, and fertility. In GnRH-deficient hpg mice, kisspeptin immunostaining in the hypothalamic nuclei, AVPV and ARC, suggested both reproductive hormone-dependent and hormone-independent contributions to pubertal kisspeptin expression. To further understand developmental influences on kisspeptin neurons, hpg mice were used to compare changes in kisspeptin immunostaining to changes in Kiss1 gene expression, and to test the hypothesis that exogenous estradiol affects hpg AVPV and ARC kisspeptin similarly to wildtype.
Methods:Kiss1 expression and kisspeptin immunostaining were compared in hpg and wildtype mice during maturation. To test response to exogenous estradiol, ovariectomized hpg and wildtype females were treated with estradiol for 1 week and, then, immunostained for kisspeptin.
Results:Kiss1 expression in the AVPV corroborated immunostaining results, demonstrating a loss of sexual-dimorphism in hpg mice. hpg ARC Kiss1 mRNA was elevated at pubertal ages, emphasizing the lack of sex steroid negative feedback. AVPV kisspeptin increased in ovariectomized wildtype females in response to estradiol treatment in a manner consistent with a positive-feedback response; estradiol-treated hpg females displayed no differences. Alternatively, estradiol treatment restored normal ARC kisspeptin staining patterns in both ovariectomized wildtype and hpg females, demonstrating that negative-feedback responses to sex steroids were intact.
Conclusions: Activation of the kisspeptinergic system is dependent upon developmental exposure to reproductive hormones. The blunted positive feedback in hpg females implies gonadal hormones are required to shape the neural mechanism necessary for ovulation.
JonkerSonnet S.
(presenting author)
12SegarJeffrey2
Division of Cardiovascular Medicine, Oregon Health & Science University
2Department of Pediatrics, University of Iowa Carver College of Medicine
Cardiac Consequences of Transfusion Following Fetal Anemia During Ovine Pregnancy
Background and Objective: Fetal anemia is a serious complication of pregnancy that can alter cardiac growth and cardiovascular physiology, and lead to fetal demise. Transfusion can improve fetal health and maternal reproductive outcome, but the cardiac consequences of recovery from anemia are unknown. For fetal hearts enlarged by anemia, we predict their mass would become normalized within 10 days following transfusion. We hypothesized that accelerated cardiac growth of anemic fetuses would cease following transfusion, and that heart weights would consequently normalize.
Methods: Fetal sheep were made anemic by isovolumetric hemorrhage starting at 75% gestation. After 10 days, fetuses were either euthanized (n = 6) or transfused to restore a normal hematocrit for 10 days, and then euthanized (n = 7). Age-matched control fetuses were studied for both experimental groups (n = 5 and n = 7, respectively). Morphometric measurements were made of isolated cardiomyocytes.
Results: Hearts (adjusted for body weight) were 31% heavier in anemic v. age-matched fetuses. Adjusted heart weight 10 days after fetal transfusion remained 25% heavier than age-matched controls. Cardiomyocyte sizes, cell cycle activity, and terminal differentiation were not different between experimental groups and their controls, and do not fully explain the sustained cardiac hypertrophy.
Conclusions: Ten days of anemia at 75% gestation causes cardiac enlargement by cardiomyocyte proliferation. Transfusion of anemic fetuses did not lead to normalization of adjusted heart weight in the recovery period. We conclude that the fetal heart responds rapidly to the adverse stimulus of anemia, but does not respond rapidly to correction of this cardiovascular stress.
WeaverLaura E.RoseJennifer A.RileyJoan K.
(presenting author)
Department of Obstetrics and Gynecology, Washington University School of Medicine
The Role of Toll-Like Receptors in Ischemia/Reperfusion-Induced Placental Injury
Background and Objective: Preeclampsia is identified by hypertension and proteinuria in the second half of pregnancy. Assigned a role in the pathophysiology of preeclampsia, oxidative stress is evident in the placenta and systemic circulation of women with preeclampsia. The production of ROS is linked with tissue injury in many diseases, and trophoblast damage is induced by hypoxia/reoxygenation via high levels of ROS. We test the hypothesis that hypoxia/reoxygenation of the placenta activates TLRs to generate ROS that mediate trophoblast injury and placental dysfunction in preeclampsia through a mechanism involving autophagy.
Methods: To detect TLR transcripts in trophoblast cells, we performed real-time PCR using TLR2-, TLR4-, and TLR6-specific primers. TLR protein expression was determined by flow cytometry. Autophagy was measured via the ratio of active cleaved LC3 to uncleaved protein by western blot.
Results: JEG-3 choriocarcinoma cells expressed TLR1, TLR2, TLR4, and TLR6 transcripts. Hypoxia increased TLR1 but not TLR2, TLR4, or TLR6 protein expression in JEG-3 cells. In addition, TLR2 but not TLR1, TLR4, or TLR6 protein was expressed in a murine trophoblast stem (TS) cell line. To establish that trophoblast cells undergo autophagy, TS cells were exposed to 10–40 μM rapamycin for 30 hours in vitro. The ratio of active cleaved to uncleaved LC3 increased when TS cells were treated with 30 μM rapamycin.
Conclusions: These initial data show proof of principle that oxygen variations alter TLR expression and that trophoblasts undergo autophagy. Future studies will dissect TLR-dependent mechanisms for oxidative stress in preeclampsia.
Department of Pediatrics, University of California, Davis, School of Medicine
Harvard School of Public HealthFamily Violence Prevention Fund
Pregnancy Control and Partner Violence among Adolescent Female Users of Family Planning Clinics
Background and Objective: Intimate partner violence (IPV—physical or sexual violence by a partner) has been associated with adolescent and unintended pregnancy. One mechanism that may explain how IPV relates to poor reproductive health is male partners' control of women's reproduction through condom refusal, abusive responses to contraceptive negotiation, pressuring women to get pregnant, keeping women from abortion, and birth control sabotage; cumulatively, these behaviors constitute pregnancy control. The extent of pregnancy control experienced by adolescents is not known. Our objective is to determine the prevalence of pregnancy control among adolescent females using confidential clinics and the association of pregnancy control with IPV.
Methods: Female clients ages 16 to 20 years (N = 567) were recruited from five family planning clinics in California to complete a 20-minute audio computer-assisted self-interview in English or Spanish about reproductive control, IPV, and pregnancy experiences.
Results: The lifetime prevalence of physical or sexual violence from an intimate partner was 50.1%. Pregnancy control was reported by 28.9% of participants (including 21.5% of clients who reported no history of IPV). IPV was associated with experiences of pressuring to prevent abortion (OR 2.25, 95% CI 1.40–3.61), pregnancy control (OR 2.08, 95% CI 1.43–3.03), and birth control sabotage specifically (OR 2.34, 95% CI 1.46–3.75). However, IPV was not associated with unintended pregnancy (OR 1.28, 95% CI 0.88–1.87).
Conclusions: IPV and pregnancy control are common among adolescent female clients of family planning clinics and are associated with each other. The impact of partners' pregnancy control on adolescent reproductive and sexual health outcomes merits further study.
HillmanJennifer B.
(presenting author)
NegriffSonyaDornLorah D.Division of Adolescent Medicine, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine
Competence and Hormonal Contraception During Adolescence
Background and Objective: Decision-making regarding reproductive health concerns is a critical area of adolescent development. Little is known about psychosocial correlates of use of different hormone contraceptive methods in adolescence. Our objective is to examine the associations among perceived competence, rule-breaking behavior, and hormone contraceptive method.
Methods: We conducted cross-sectional analyses of 209 post-menarcheal girls enrolled in a longitudinal study. Girls were primarily Caucasian (62.8%) or African-American (32.8%). Competence (activities and social) and rule-breaking behavior scales were assessed by the Youth Self Report (YSR; adolescent report) and the Child Behavior Checklist (CBCL; parent report). Three groups were created: no hormone (n = 142); COCs/patch (n = 41), using either combined oral contraceptive pills or the transdermal patch; and depot medroxyprogesterone acetate (DMPA) (n = 20).
Results: Multivariate analysis of variance revealed a significant main effect of hormone type on competence (p = 0.003). The DMPA group had significantly lower CBCL activities and social competence, and lower YSR social competence when compared with the no hormone and COCs/patch groups. The COCs/patch group scored significantly lower on the YSR activities competence when compared with the no hormone group, but was not different from the DMPA group. Lastly, there was a main effect of hormone type on CBCL rule-breaking behavior (p = 0.029), with the DMPA group having significantly higher rule-breaking behavior than the two other groups. There was no effect of hormone type on YSR rule-breaking behavior.
Conclusions: Parental and adolescent reports of perceived competence appears to be associated with hormone contraception use. For rule-breaking behavior, parental perception may be more relevant to hormone use.
Department of Obstetrics, Gynecology and Reproductive Sciences
Department of Epidemiology, University of Pittsburgh
Department of Epidemiology, Institute of Public Health, University of Aarhus
Department of Epidemiology, University of California, Los Angeles
Severity and Recurrence of Preterm Birth and Maternal Cardiovascular Disease Risk
Background and Objective: Women with preterm births (PTB) may have excess cardiovascular disease (CVD) risk, but mechanisms linking these conditions are unknown. We hypothesized that a common predisposition to both conditions would be reflected by a more pronounced relationship between early or recurrent PTB and CVD, as these tend to aggregate in families.
Methods: We related PTB severity (earlier gestational age at delivery) and recurrence (at least two births) among women who gave birth between 1973 and 1983 in Denmark (n = 426,865) to maternal CVD morbidity and mortality. Birth data were linked to CVD hospitalizations and deaths identified in national registers via ICD codes (1977 to 2006) and data were analyzed using Cox proportional hazards models.
Results: Women with a prior PTB had excess CVD after adjustment for age, parity, education, and birth year (HR 1.26, 95% CI 1.22–1.31). This was only modestly attenuated when women with preeclampsia or small for gestational age births were excluded, and the relationship was stronger for CVD mortality (HR 1.91 [1.67, 2.18]). Among women with only one birth, CVD risk increased with early (<32 weeks, HR 1.66 [1.44, 1.91]) v. moderate (35–36 weeks, HR 1.39 [1.30, 1.48]) preterm births. Among women with at least two births, recurrent PTB was associated with modestly higher risk for CVD compared to one PTB. Sensitivity analysis suggested that confounding by smoking only partly explained these associations.
Conclusions: Associations between PTB and later life maternal CVD could reflect a common underlying predisposition related to both conditions. Preterm births may identify women at increased risk for CVD.
Department of Biochemistry and Biophysics, University of North Carolina School of Medicine
Division of Hematology and Oncology of the Department of Medicine, University of North Carolina School of MedicinePlacental Analytics
Department of Obstetrics and Gynecology, University of North Carolina School of Medicine
Placental Pathology and Pregnancy Outcome in Sickle Cell Disease: A Pilot Study
Background and Objective: Pregnancy complications in women with sickle cell disease (SCD) include preterm birth, delivery of small for gestational age (SGA) infants, and potential hypertension of pregnancy. The role that placental pathology may play in these complications has never been examined. We sought to explore a potential connection between placental inflammatory and vascular pathology and pregnancy outcome in SCD.
Methods: For this pilot study, we obtained pregnancy outcome, blood pressure, and placental pathology data from the Pregnancy, Infection and Nutrition study, from which 23 subjects were identified as having SCD and placental pathology data were available for six of them. Placental pathology was divided into vascular and inflammatory categories, and a severity score was assigned to pathology as 0 (none) to 4 (pronounced).
Results: Three out of the six placentas from pregnant women with SCD had some degree of pathology, though none was pronounced. Of those SCD placentas with no pathology detected, there was only one instance of delivery of an SGA infant, no preterm births, and no rise in systolic blood pressure across pregnancy. The median rise in systolic blood pressure in subjects with placental pathology was 15.0 mmHg (range, 8, 24). Both cases of preterm birth occurred in subjects with either mild vascular and inflammatory placental pathology or moderate vascular pathology. The subject with both vascular and inflammatory placental pathology demonstrated the worst pregnancy outcome.
Conclusions: Placental pathology, especially multiple comorbid types of placental pathology, may play a role in poor pregnancy outcome in SCD.
YangPeixin
(presenting author)
1Albert ReeceE.12
Department of Obstetrics, Gynecology, and Reproductive Sciences
Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine
Thioredoxin Ameliorates Hyperglycemia-Induced Embryonic Vasculopathy via Blockade of the Pathways Leading to Apoptosis
Background and Objective: Congenital malformations occur in up to 10% of babies born to diabetic women. Hyperglycemia causes embryonic vasculopathy that leads to embryonic lethality or malformations. Maternal diabetes induces apoptosis in Flk1+ progenitors and reduces the number of blood islands resulting in aberrant vasculogenesis. Maternal diabetes induces embryonic vasculopathy through two distinct sets of molecular events: activation of the ASK1/iNOS pathway and reduction of HIF-1α/VEGF pathway. Thioredoxin (Trx) is an antiapoptotic and antioxidative protein. Diabetic embryonic vasculopathy is an oxidative stress and apoptotic disease process. Therefore, we reason that Trx may have preventive effects on this disease process. Our objective is to examine the effect of Trx on hyperglycemia-induced aberrant pathways and consequent vasculopathy.
Methods: Embryonic day 7 mouse conceptuses were cultured under euglycemic (150 mg/dl) and hyperglycemic (300 mg/dl glucose) conditions with or without 0.1, 0.5, or 2.0 μg/ml Trx. Yolk sac vasculatures of 48-hour-cultured conceptuses were morphologically assessed. Levels of pASK1 and HIF-1α were determined in 24-hour-cultured conceptuses with or without 2 μ g Trx treatment.
Results: Hyperglycemia significantly decreased vasculature morphological scores. Vasculature morphological scores in conceptuses cultured in hyperglycemia plus 0.5 or 2 μg/ml Trx were significantly higher than those in conceptuses cultured in hyperglycemia alone. Hyperglycemia reduced HIF-1α levels, whereas Trx treatment reversed hyperglycemia-reduced HIF-1α levels. Hyperglycemia significantly increased the levels of pASK1, and Trx blocked hyperglycemia-induced ASK1 activation.
Conclusions: Trx can block ASK1 activation and also reverse HIF-1α reduction induced by hyperglycemia, thereby preventing apoptosis and subsequent embryonic vasculopathy.
FitzgeraldColleen M.Department of Physical Medicine and Rehabilitation, Rehabilitation Institute of Chicago, Northwestern University Feinberg School of Medicine
Use of Pelvic Musculoskeletal Ultrasound To Investigate the Etiology of Pregnancy-Related Pelvic Girdle Pain
Background and Objective: Pregnancy-related pelvic girdle pain (PGP) is common and can be disabling. Ultrasound (US) may definitively diagnose PGP and identify those patients at greatest risk for severe pain. Our objective is to develop a dynamic US measurement protocol of the pubic symphysis (PS), rectus abdominus (RA), and pelvic floor muscles (PFM) in pregnancy.
Methods: A standardized US assessment protocol was established in 10 pregnant test subjects without pain during the second or third trimester. Using a linear US transducer externally at 18 MHz and 4 cm of depth, PS anatomic locations and parameters (width and vertical shift) were determined at the superior and inferior joint margins in supine, in Patrick's Faber (PF) position, with straight leg raise (SLR), with double legged stance, and with single leg stance. Midline width measurements of the RA muscle just above, at, and below the umbilicus were taken in supine and in standing. With a curvilinear transducer at 5 MHz and 6 cm of depth, qualitative external PFM assessment was performed in supine and standing. All measures were repeated three times at each site and position, and then 1 week apart.
Results: US measurements of the PS had good test-retest reliability in supine, SLR, and PF positions but not in standing. RA measurements were determined above and below the umbilicus in supine but were not feasible in standing or at the umbilicus. US of the PFM could not be performed externally.
Conclusions: This US protocol will be used to determine if US measurements distinguish pregnancy-related PGP.
Perinatal Research Center, University of Colorado, Denver
Department of Pediatrics, University of Colorado, Denver
Intrauterine Growth Restriction Results in Increased Insulin-Stimulated Proliferation but Not Hypertrophy in Fetal Myocytes
Background and Objective: Reduced fetal skeletal muscle growth is a hallmark of intrauterine growth restriction (IUGR) and leads to increased risk for adult insulin resistance; however, the causative mechanisms are unknown. Our objective is to determine the effect of insulin on cellular proliferation and protein synthesis in primary cultured myocytes from ovine IUGR and control fetuses.
Methods: Studies were performed using an established ovine model of placental insufficiency and IUGR. Fetal myoblasts were harvested from control (n = 6) and IUGR (n = 3) fetuses at ∼90% of gestation, cultured in increasing insulin concentrations, and counted at 3 and 5 days to measure cell proliferation. Fully differentiated myotubes were serum starved overnight and incubated in insulin for up to 6 hours to measure protein synthesis rates using L-[3,4,5-3H(N)] leucine incorporation.
Results: IUGR fetuses weighed 43% less, had 67% percent lower blood oxygen contents, and had 40% lower plasma glucose concentrations compared to control fetuses (p < 0.01). Insulin increased proliferation in cells from both control and IUGR fetuses; however, the proliferation rate was twofold higher in IUGR cells (p = 0.005). Insulin increased protein synthesis rates in a dose-dependant manner (p = 0.009), but the responses did not differ between control and IUGR.
Conclusions: Myoblasts from IUGR fetuses demonstrate strikingly increased capacity for proliferation in response to insulin compared to cells from control fetuses; however, this is not associated with a further increase in protein synthesis in mature myotubes. Thus, IUGR fetal myocytes have a strong capacity for growth (myogenesis) when exposed to insulin, but limited ability for catch-up growth by hypertrophy.